CURRICULUM VITAE (Revised March 1st, 2016)

Name: Marc Moss, M.D. Date of Birth: September 12, 1961 Title: Roger S. Mitchell Professor of Medicine Place of Birth: Philadelphia, PA Division of Pulmonary Sciences and Critical Care Medicine. Citizenship: United States University of Colorado School of Medicine. Denver, Colorado Address: University of Colorado Denver Division of Pulmonary Sciences and Critical Care Medicine Research 2, Box C272 12700 East 19th Ave. Aurora, CO 80045 Email: Marc.Moss@ucdenver.edu EDUCATION 1979-1983 Amherst College; Amherst, Massachusetts B.A., Biology 1983-1987 University of Pennsylvania; Philadelphia, Pennsylvania M.D., School of Medicine 1992-1994 University of Colorado; Denver, Colorado Department of Preventative Medicine and Biometrics 4 semesters (11 credit hours) in Epidemiology 4 semesters (11 credit hours) in Biostatistics 2004-2005 Woodruff Leadership Academy Emory University School of Medicine Atlanta, GA ACADEMIC APPOINTMENTS 2006-present Roger S. Mitchell Professor of Medicine (with tenure) Division of Pulmonary Sciences and Critical Care Medicine University of Colorado School of Medicine 2001-2006 Associate Professor of Medicine Division of Pulmonary and Critical Care Medicine Emory University School of Medicine 1995-2001 Assistant Professor of Medicine Division of Pulmonary and Critical Care Medicine Emory University School of Medicine 1994-1995 Instructor, Pulmonary Sciences and Critical Care Medicine University of Colorado Health Sciences Center

1991-1994 Fellow, Pulmonary Sciences and Critical Care Medicine University of Colorado Health Sciences Center 1991 Visiting Professor of Medicine Ban Phai Hospital, Ban Phai, Thailand 1988-1990 Resident, Internal Medicine Hospital of the University of Pennsylvania 1987-1988 Intern, Internal Medicine Hospital of the University of Pennsylvania PROFESSIONAL EXPERIENCE AND APPOINTMENTS 2013-present Vice Chair of Clinical Research Department of Medicine University of Colorado School of Medicine 2008-present Program Director - Education, Training, and Career Development Colorado Clinical Translational Science Institute University of Colorado School of Medicine 2008-present Program Director – KL2 program Colorado Clinical Translational Science Institute University of Colorado School of Medicine 2006-present Head of Critical Care Medicine Division of Pulmonary Sciences and Critical Care Medicine University of Colorado School of Medicine 2001-2006 Chief, Section of Pulmonary and Critical Care Grady Memorial Hospital, Emory University 2000-2004 Director, Medical and Cardiac Intensive Care Unit Grady Memorial Hospital, Emory University 1996-2000 Director, Medical Intensive Care Unit Crawford Long Hospital, Emory University 1996-2000 Director, Pulmonary Physiology Laboratory Crawford Long Hospital, Emory University 1996-2000 Associate Director, Respiratory Care Services Crawford Long Hospital, Emory University BOARD CERTIFICATION National Board of Medical Examiners - 1988 Board of Internal Medicine - 1990 Board of Pulmonary Medicine - 2004 Board of Critical Care Medicine - 2005

JOURNAL REVIEW WORK JAMA New England Journal of Medicine American Journal of Respiratory and Critical Care Medicine Alcoholism: Clinical and Experimental Research American Journal of Medicine Chest Critical Care Medicine Intensive Care Medicine EDITORIAL BOARDS American Journal of Respiratory and Critical Care Medicine PRESENT NIH FUNDING 1. NIH NHLBI-HR-05-04 Clinical Center for the Prevention and Early Treatment of Acute Lung Injury Entire Project: 04/01/14 – 3/30/21 Role on Project: Principal Investigator Annual Direct Costs: approximately $400,000 Percent Effort: 1.2 months Specific Aims: To enroll patients with acute lung injury into clinical trials 2. NIH UL1-RR025780 Colorado Clinical and Translational Science Institute Entire Project: 06/01/08-5/31/18 Role on Project: Program Director of Education, Training, and Career Development Annual Direct costs: $1,029,893 Percent Effort: 3.0 months Specific Aims: To develop education, training, and career development programs for clinical

and translational research. 3. NIH KL2RR025779 Colorado Clinical and Translational Science Institute – KL2 program Entire Project: 06/01/08-5/31/18 Role on Project: Program Director Annual Direct Costs: $459,006 Percent Effort: 0.6 months Specific Aims: To build an institutional K12 program under the auspices of the Colorado

Clinical and Translational Science Institute 4. NIH K24 HL089223 Enhancing patient-oriented research in acute lung injury Entire Project 07/01/07-9/30/17 Role on Project: Principal Investigator Annual Direct Costs: $144,558 Percent Effort: 3.6 months Specific Aims: To build a patient-oriented research program in the area of acute lung injury 5. NIH 1R01NR011051 – 01 The diagnosis and treatment of critical illness polyneuromyopathy Entire Project 06/01/09-9/30/14 (one year no cost extension)

Role on Project: Principal Investigator Annual Direct Costs: $436,924 Percent Effort: 3.0 months Specific Aims: To identify new diagnostic techniques and determine the efficacy of physical

therapy for patients with critical illness polyneuromyopathy PREVIOUS EXTRAMURAL GRANTS Substance Abuse and the Adult Respiratory Distress Syndrome. American Lung Association Research Grant. Principal Investigator. July 1996-June 1998. Acute Lung Injury: Alcoholism and Glutathione Depletion. RO1 grant. Co-Investigator. April 1999-March 2003. Alcoholism and Lung Injury: The Role of Cirrhosis and Glutathione Deficiency. R21 grant. Principal Investigator. September 2000-August 2003. NIAAA Institutional training grant in alcohol research. T32 AA13528-01. Associate Director for Clinical Research. 7/1/01-6/30/06. NIAAA Alcohol Research Center Grant. P50 AA013757-01. Clinical Director of the Center, and Principal Investigator of Clinical Core and Project #6 entitled, “The epidemiological association between chronic alcohol abuse and ARDS”. 1/1/03-7/01/06. NIH R01 HL90991-01 Viral-induced adaptation of neutrophil response in ARDS. R0-1 grant. Co-Investigator. July 2007-July 2008. NIH P50 HL074024-01 Specialized Center of Clinically Oriented Research in Translational Research in Acute Lung Injury – University of Michigan Health System. Principal Investigator –Emory University/University of Colorado. July 2004-July 2008. NIH R01 AA014435 Alcohol abuse and alveolar epithelial barrier function Principal Investigator 06/01/04-9/30/11 5UL1RR025780 Trial of remote monitoring for multicenter clinical trials Co-Principal Investigator 09/26/09-9/25/13 PREVIOUS INDUSTRY SPONSORED GRANTS (Only including grants on which I was the Principal Investigator) Randomized, Placebo-Controlled Trial of E5 Monoclonal Antibody in Patients with Severe Gram Negative Sepsis. Principal Investigator. January 1996-April 1997. A Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Procysteine in the Treatment of Patients with Acute Respiratory Distress Syndrome. Principal Investigator. June 1997- April 1998. A Multi-Center, Phase IIb, Randomized, Placebo-Controlled Trial of Affinity Purified, Anti-Tumor Necrosis Factor Alpha, Ovine Fab, for injection in Sepsis Syndrome. Principal Investigator. September 1997- June 1998.

A Phase II Study to Determine the Efficacy and Safety of LY315920 in Patients with Severe Sepsis. Principal Investigator. November 1998- August 1999. Venticute (rSP-C Surfactant) for the Treatment of Acute Respiratory Distress Syndrome. Principal Investigator, October 1999-October 2000. A Prospective Multicenter Study of Anemia in the Intensive Care Unit. Principal Investigator, October 2000-March 2001. A Phase III Study to Demonstrate the Safety and Efficacy of Recombinant Platelet-Activating Factor Acetylhydrolase (rPAF-AH) for Reducing 28 Day All Cause Mortality in Patients with Severe Sepsis. Principal Investigator, September 2001-December 2002. A Multi-center, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Surfaxin Delivered via Bronchopulmonary Segmental Lavage to Standard of Care in Patients with Acute Respiratory Distress Syndrome (ARDS). Principal Investigator, October 2002 – January 2004. AWARDS AND HONORS American Lung Association Edward Livingston Trudeau Scholar for the research grant entitled “Substance Abuse and the Adult Respiratory Distress Syndrome”. This was one of the top six grants out of 220 applications selected for this honor. 1996-1998. Golden Apple Award for Excellence in Teaching at Crawford Long Hospital. Awarded by the Emory University Medical Housestaff. 1997-1998 and 1998-1999. Golden Apple Award for Excellence in Teaching at Grady Memorial Hospital. Awarded by the Emory University Medical Housestaff 2000-2001, 2002-2003, and 2005-2006. Emory University Attending Teaching Award. Awarded by the Emory University Internal Medicine Residency Program. 2002. Emory University Dean’s Clinical Investigator Award 2003-2006. This is an award of $50,000 per year for three years. J. Willis Hurst Internal Medicine Residency Program Mentorship Award. Awarded by the Emory University Internal Medicine Residency Program. 2004. Pulmonary Star Award from the Division of Pulmonary, Allergy and Critical Care Medicine, Emory University School of Medicine. 2004. Best Doctors in America 2007-2008, 2008-2009, 2009-2010, 2010-2011. Selected as the Who’s Who in the American Thoracic Society for December. 2007. American Thoracic Society Presidential Commendation for service on ATS committees 2008. Pfizer Visiting Professor at the University of Washington. 2010. American Thoracic Society Presidential Commendation for service on the International Conference 2010.

INTERNATIONAL COMMITTEES Member of the Integrative Review Group for the Canada Foundation for Innovation (CFI). This is an independent corporation created by the Government of Canada to fund research infrastructure. 2007-2008. NIH and FDA COMMITTEES NIH: NHLBI Task Force on Research in Cardiopulmonary Dysfunction, Critical Care Medicine. 1993-1994. NIH:NHLBI Special Emphasis Panel to review supplemental grant applications for the FACTT trial as part of ARDS network. 2000. NIH:NHLBI Working Group: Research opportunities in the clinical epidemiology of lung injury and critical illness. 2000-2001. NIH:NHLBI: External reviewer for ARDS educational information, 2003. NIH:NHLBI Special Emphasis Panel to review grant applications for the ARDS network. 2005. NIH:NIAAA Special Emphasis Panel to review grant application for Alcohol Centers. 2005. NIH: NHLBI Workshop participant: “Adult stem cells, lung biology and lung disease”. 2005. NIH:NIAAA Special Emphasis Panel: selected member of panel to review scoring of eight Alcohol Center applications. 2005. FDA National Pulmonary-Allergy Drugs Advisory Committee, 2004-2008. NIH:NIAAA Special Emphasis Panel: ZAA1 HH61 Fellowships Review meeting, 2006. NIH: NHLBI: Head of the Pediatric Subcommittee for the ARDS network: 2007-2009. NIH: NHLBI: Member of the ARDS network pathogenesis committee: 2007-present. NIH: NHLBI: Member of the ALTA study committee for the ARDS network: 2007-2010. NIH: NHLBI Workshop participant: “Adult stem cells, lung biology and lung disease”. 2007. NIH: Health Services Organization and Delivery Study Section, Ad hoc reviewer, 2007-2009. NIH: National Institute of Aging (GEMSSTAR), Ad hoc reviewer, 2011-present. American Association for the Advancement of Science (AAAS) research competitiveness program, ad hoc reviewer, 2012-present. NIH: NHLBI: Chair of DSMB for pediatric insulin trial. 2012-present NIH: NHLBI Member of K23/K24/K25 study section, 2012-2013 NIH: NINR member of NRCS study section, 2013-2014

OTHER NATIONAL AND LOCAL COMMITTEES GUIDe (Guidelines for Use of Intensive Care in Denver), Member of the Adult Intensive Care Subcommittee. 1993-1995. Ethics Committee at Crawford Long Hosptial. 1996-1997. Critical Care Committee at Crawford Long Hospital. 1996-2000. Critical Care Committee at Grady Memorial Hospital. 2000-2003. Human Tissue Procurement and Bank Service Advisory Committee, Emory University School of Medicine. 2002-2004. Centers for Disease Control and Prevention: Severe Acute Respiratory Syndrome (SARS) Clinical Working Group. 2003-2004. American Thoracic Society: Critical Care Assembly Program Committee. 2001-2003, 2005-2009. American Thoracic Society: Education Committee. 2002-2004. American Thoracic Society: Communications Committee. 2002-2004. American Lung Association of Georgia / Georgia Thoracic Society: Scientific Review Committee. 2003. American Thoracic Society: Communications and Media Relations Committee Chairman. 2004-2008. American Thoracic Society: Task Force on Clinicians. 2004-2006. American Thoracic Society: Critical Care Planning Committee. 2004-2005 and 2006-2007. American Lung Association Research Fellowship Grant Scientific Review Committee. 2005-2009 American Thoracic Society: Relationships and Awareness Strategy Group. 2005-2006. American Thoracic Society: Clinical Year in Review Committee. 2005-2008. American Thoracic Society: Board of Directors: 2006-2008, 2009-2011. American Thoracic Society: Organizational Structure Task Force: 2007-2008 American Thoracic Society: Chairmen of Web Editor Search Committee: 2007 American Thoracic Society: Chairman of the International Conference Committee: 2008-2011 American Thoracic Society: Clinicians Advisory Committee: 2008-2011 American Thoracic Society: Program and Budget Committee: 2009-2011 American Thoracic Society: Awards Committee: 2009-2011

American Thoracic Society: Task Force on Career Development: 2009-2011 American Journal of Respiratory and Critical Care Medicine Editorial Board: 2010-present American Thoracic Society: Presidential Commission on Patient Involvement: 2011-2012 American Thoracic Society: Nominating Committee: 2011 American Thoracic Society: Critical Care Nominating Committee Chairman: 2012-2013. American Thoracic Society: Secretary-Treasurer: 2014-2015. NATIONAL LECTURES 1. “The epidemiology of the acute respiratory distress syndrome” Medical Grand Rounds, Danbury Hospital, Danbury, CT; 1997. 2. “Diabetic patients with septic shock have a decreased incidence of the acute respiratory distress syndrome (ARDS)” American Thoracic Society International Conference, San Francisco, CA; 1997. 3. “Acute respiratory distress syndrome (ARDS) in adults” Medical Grand Rounds, Northside Hospital, Atlanta, GA; 1998. 4. “Who develops ARDS: the role of co-morbid conditions” American Thoracic Society International Conference, Chicago, IL; 1998. 5. “Chronic alcohol abuse and acute lung injury: The experimental and epidemiological evidence”

American Thoracic Society International Conference, San Diego, CA; 1999. 6. “Acute respiratory distress syndrome, what is new?” Medical Grand Rounds, University of

Puerto Rico School of Medicine, San Juan, PR, 2000. 7. “The role of comorbidity in the acute respiratory distress syndrome” Medical Grand Rounds,

Medical College of Wisconsin, Milwaukee, WI, 2000. 8. “Racial differences in the incidence of ARDS in the United States: Analysis of national hospital

discharge data (1994-1998)”. American Thoracic Society International Conference, San Francisco, CA; 2001.

9. “Alcohol, Diabetes, and ARDS” Invited Conference Speaker, 15th Annual Kjeldgaard Day

Symposium, Maine Medical Center, Portland, ME, 2001. 10. “ARDS and the role of co-morbidity” Medical Grand Rounds, Morehouse School of Medicine,

Atlanta, GA, 2002. 11. “Translational Research: A Bidirectional Flow of Ideas” American Thoracic Society

International Conference, Atlanta, GA; 2002. 12. “Alcohol abuse and bacterial pneumonia” American College of Chest Physicians International

Conference, San Diego, CA; 2002.

13. “ARDS and chronic alcohol abuse” American College of Chest Physicians International

Conference, San Diego, CA; 2002. 14. “Alcohol abuse and ARDS: from the bedside to the bench and back again” Visiting Professor,

University of Washington in Seattle, 2003. 15. “The impact of population heterogeneity in translational ICU studies” American Thoracic

Society International Conference, Seattle, WA; 2003. 16. “Alcohol abuse and dependence: An unrecognized problem” American Thoracic Society

International Conference, Seattle, WA; 2003. 17. “Chronic alcohol abuse in the ICU” Ozark Chest Conference, Missouri Thoracic Society, Lake

of the Ozarks, MO; 2003. 18. “ARDS” First Annual Wake Forest Critical Care Conference, Blowing Rock, NC; 2003. 19. “The epidemiology of sepsis and ARDS” Pulmonary Grand Rounds, University of Michigan,

Ann Arbor, MI; 2003. 20. “Alcohol abuse and dependence: An unrecognized problem” American Thoracic Society

International Conference, Orlando, FL; 2004. 21. “The epidemiology of sepsis in the United States” Pulmonary Grand Rounds, Johns Hopkins

School of Medicine, Baltimore, MD; 2004. 22. “The epidemiology of sepsis and ARDS” Medical Grand Rounds, University of Nebraska,

Omaha, NE; 2004. 23. “Sepsis and ARDS” Medical Grand Rounds, University of South Alabama, Mobile, AL. 2005. 24. “Heterogeneity in ARDS patients: Why one therapy may not work for all patients” American

Thoracic Society International Conference, San Diego, CA; 2005. 25. “Epidemiology of Sepsis” Specialized Clinical Centers of Research in Acute Lung Injury

Conference, San Francisco, CA; 2005. 26. “Preventing alcohol related complications: more than a yellow bag” American Thoracic

Society International Conference, San Diego, CA; 2006. 27. “The epidemiology of ARDS and sepsis” Medical Grand Rounds, University of Colorado at

Denver and Health Sciences Center, Denver, CO; 2006 28. “Alcohol and the critically ill patient” American Thoracic Society International Conference, San

Francisco, CA; 2007. 29. “Clinical Year in Review: Severe Sepsis” American Thoracic Society International Conference,

San Francisco, CA; 2007.

30. “The global epidemiology of severe sepsis: The big picture” American Thoracic Society International Conference, San Francisco, CA; 2007.

31. “Alcohol abuse and ARDS” Alcohol and Trauma 2007, Satellite symposium of the 30th annual

meeting of the Shock Society, Baltimore, MD; 2007. 32. “The epidemiology of sepsis in the United States” University of Michigan Pulmonary and

Critical Care Symposium, Ann Arbor, MI; 2007. 33. “Alcohol abuse in the critically ill patient” University of Michigan Pulmonary and Critical Care

Symposium, Ann Arbor, MI; 2007. 34. “Clinical and Translational Research in the ICU” Critical Care Research Seminar at the Mayo

Clinic, Rochester, MN; 2008. 35. “The epidemiology of ARDS and sepsis” Critical Care Grand Rounds at the Mayo Clinic,

Rochester, MN; 2008. 36. “Alcohol Abuse and the critically ill patient” Critical Care Grand Rounds, Denver Health and

Hospitals, Denver, CO; 2008 37. “Neuromuscular weakness in the ICU” Fellows conference at the Mayo Clinic, Rochester, MN;

2008. 38. “Acute respiratory distress syndrome and sepsis: An epidemiological perspective” The Attilio

D. Renzetti Jr., M.D. Honorary Endowed Lectureship. University of Utah School of Medicine, Salt Lake City, UT; 2008.

39. “The diagnosis and treatment of weakness in critically ill patients” Pulmonary Grand Rounds.

University of Utah School of Medicine, Salt Lake City, UT; 2008 40. “Alcohol abuse and the critically ill patient” Medical Grand Rounds, Boulder Community

Hospital, Boulder, CO; 2008 41. “Alcohol abuse and the critically ill patient” Medical Grand Rounds, Longmont Community

Hospital, Longmont, CO; 2009 42. “ARDS” Medical Grand Rounds, University of South Alabama, Mobile, AL; 2009 43. “ARDS: An Update” The 6th UCLA Pulmonary and Critical Care Update Course, Santa Monica,

CA; 2009 44. “Managing Complications of Ethanol Abuse” The 6th UCLA Pulmonary and Critical Care

Update Course, Santa Monica, CA; 2009 45. “Sepsis, Alcohol, and Drug Abuse” International Sepsis Forum Meeting, Chicago, IL; 2009 46. “TRALI: Lessons from the Lab” Society of Critical Care Medicine’s 39th Critical Care

Congress, Miami, FL; 2010.

47. “The diagnosis and treatment of weakness in critically ill patients” Pulmonary Grand Rounds. University of Washington School of Medicine, Seattle, WA; 2010.

48. “The epidemiology of sepsis in the United States” Internal Medicine Grand Rounds, University

of Washington School of Medicine, Seattle, WA; 2010. 49. “How to perform translational research? Creating the optimal environment while avoiding

barriers” National Pre-doctoral Clinical Research Training Program Meeting, St. Louis, MO 2010.

50. “The Epidemiology of the Acute Respiratory Distress Syndrome and Sepsis” Medical Grand

Rounds, The Ohio State University School of Medicine, Columbus, OH; 2010. 51. “Alcohol abuse in the MICU” Society of Critical Care Medicine’s 40th Critical Care Congress,

San Diego, CA; 2011. 52. “Why is your ICU patient weak?” Society of Critical Care Medicine’s 40th Critical Care

Congress, San Diego, CA; 2011. 53. “360 Approach to Research Education and Training” Clinical Translational Sciences meeting,

Washington, DC, 2012. 54. “How to implement change” American Thoracic Society International Conference, San

Francisco, CA; 2012. 55. “Is there anything new that you need to know about the Acute Respiratory Distress Syndrome

(ARDS)?” Medical Grand Rounds, University of Louisville School of Medicine, Louisville, KY 2013.

56. “Uncovering the epidemic of psychological distress in critical care nurses” Pulmonary Grand

Rounds, University of Louisville School of Medicine, Louisville, KY 2013. 57. “Statins for Acutely Injured Lungs from Sepsis: Come SAIL Away” Society of Critical Care

Medicine’s 42th Critical Care Congress, San Juan, PR, 2013. 58. “Life After the ICU: Neuromuscular Function” Society of Critical Care Medicine’s 42th Critical

Care Congress, San Juan, PR, 2013. 59. “Uncovering the epidemic of psychological distress in critical care nurses” American Thoracic

Society International Conference, Philadelphia, PA; 2013. 60. “How to implement change” American Thoracic Society International Conference, Philadelphia,

PA; 2013. 61. “What you need to know about ARDS” Medical Grand Rounds –Tisdale Lecture Series,

University of Vermont; Burlington, VT, 2014 62. “ARDS” American Thoracic Society International Conference, San Diego, CA; 2014. 63. “Defining the terms: Stress, Burnout Syndrome, and Post Traumatic Stress Disorder” Society of

Critical Care Medicine’s 44th Critical Care Congress, Phoenix, AZ; 2015.

64. “Top 5 ICU Emergencies” American Thoracic Society International Conference,, Denver, CO;

2015 65. “Sepsis and ARDS: How research is transforming patients’ lives” NIH/NHLBI Congressional

Hearing, Washington, D.C. 2015 INTERNATIONAL LECTURES 1. “Racial and gender differences in acute respiratory distress syndrome (ARDS) deaths in the

United States (1979-1996).” NATO sponsored Advanced Study Institute, Etiology and Treatment of Acute Lung Injury: From Bench to Bedside. Corfu, Greece, 2000.

2. “Trends in Acute Respiratory Distress Syndrome (ARDS) Deaths in the United States: Analysis

of Multiple-Cause Mortality Data (1979-1996)” American Thoracic Society International Conference, Toronto, Canada; 2000.

3. “Alcohol abuse, ARDS, and multiple organ dysfunction” 4th Annual Margaux Conference, Sintra,

Portugal, 2002. 4. “Sepsis: Race, Gender, and Co-Morbidity” International Sepsis Forum Meeting, Cambridge,

England; 2004. 5. “Chronic alcohol abuse, acute respiratory distress syndrome, and multiple organ failure”

Simposio Mostra Anestesia Rianmiazione e Tereapia Intensiva (SMART) Conference, Milan, Italy; 2006.

6. “Myopathies in critical illness: characterization and nutritional aspects” Simposio Mostra

Anestesia Rianmiazione e Tereapia Intensiva (SMART) Conference, Milan, Italy; 2006. 7. “Utilization of physical therapy in intensive care units in the United States: a survey” First

Internaional Meeting of physical rehabiliation in the critically ill, Toronto, Canada, 2008. 8. “The clinical presentation of ICU-acquried weakness” American Thoracic Society International

Conference, Toronto, Canada; 2008 9. “Risk and Short-term prevention in medical patients” Risk and Prevention of Alcohol Use

Disorders, Der. 11 Hauptstadkongress der DGAI, Berlin, Germany, 2009 10. “Alcohol disorders in ARDS” Risk and Prevention of Alcohol Use Disorders, Der. 11

Hauptstadkongress der DGAI, Berlin, Germany, 2009 11. “Diagnostic testing and clinical trial design” ATS MECOR course, Bogota, Columbia, 2010. 12. “Alcohol disorders in ARDS” Update on Alcohol Research at the University of Colorado, Der.

11 Hauptstadkongress der DGAI, Berlin, Germany, 2011 13. “Unhealthy alcohol use, acute lung injury, and the critically ill patient” City Wide Visiting

Professor Grand Rounds, University of Toronto, Toronto, Canada, 2012.

14. “Uncovering the epidemic of psychological distress in critical care nurses” Interdepartmental Division of Adult Critical Care Medicine Lecture, University of Toronto, Canada, 2012.

15. “Consequences of Burnout in the ICU” American College of Chest Physicians (CHEST)

International Conference, Montreal, Canada; 2015. 16. “ICU weakness –Clinical Manifestations” Critical Care Canada Forum, Toronto, Canada; 2015. 17. “Editorial comments on the plenary session” Critical Care Canada Forum, Toronto, Canada;

2015. SYMPOSIUM CHAIRMAN AT NATIONAL AND INTERNATIONAL MEETINGS 1. Co-Chairman, Critical Care Track Symposium, “Building the Critical Care Clinical Research

Laboratory: A Practical Approach” American Thoracic Society International Conference, Atlanta, GA; 2002.

2. Co-Chairman, Critical Care Track Symposium, “Five special problems in the ICU: Cirrhosis,

alcohol abuse, pregnancy, HIV, and care for the elderly” American Thoracic Society International Conference, Seattle, WA; 2003.

3. Co-Chairman, Post-Graduate Course, “Special populations in the ICU: The effects of chronic illness

on therapy and outcome in the critically ill” American Thoracic Society International Conference, Orlando, FL; 2004.

4. Co-Chairman, Scientific Symposium. “Future pharmacological therapies for ARDS: How to repair

the injured lung” American Thoracic Society International Conference, San Diego, CA; 2005. 5. Co-Chairman, Pulmonary Board Review Session, American College of Chest Physicians

International Conference, Montreal, Canada; 2005. 6. Co-Chairman, Critical Care Track Symposium, “Prophylactic therapy in the ICU: Preventing

complications before they occur” American Thoracic Society International Conference, San Diego, CA; 2006.

7. Co-Chairman, Clinical Year in Review, American Thoracic Society International Conference, San

Diego, CA; 2006. 8. Co-Chairman, Scientific Symposium. “Basic cell biology in critical care” Simposio Mostra

Anestesia Rianmiazione e Tereapia Intensiva (SMART) Conference, Milan, Italy; 2006. 9. Co-Chairman, Scientific Symposium. “Autoimmune diseases in ICU” Simposio Mostra Anestesia

Rianmiazione e Tereapia Intensiva (SMART) Conference, Milan, Italy; 2006. 10. Co-Chairman, Pulmonary Board Review Session, American College of Chest Physicians

International Conference, Salt Lake City, UT; 2006. 11. Co-Chairman, Scientific Symposium. “The effects of alcohol use in the critically ill: Lessons from

bench to bedside” American Thoracic Society International Conference, San Francisco, CA; 2007.

12. Co-Chairman, Critical Care Track Symposium, “Update on the diagnosis and treatment of severe sepsis” American Thoracic Society International Conference, San Francisco, CA; 2007.

13. Co-Chairman, Clinical Year in Review, American Thoracic Society International Conference, San

Francisco, CA; 2007. 14. Moderator, Scientific Session. “Lung injury and repair” 50th Thomas Petty Aspen Lung Conference,

Aspen, CO; 2007 15. Co-Chairman, Pulmonary Board Review Session, American College of Chest Physicians

International Conference, Chicago, IL; 2007. 16. Co-Chairman, Clinical Year in Review, American Thoracic Society International Conference,

Toronto, Canada, 2008. 17. Co-Chairman, Scientific Symposium. “Late Breaking Clinical Trials” American Thoracic Society

International Conference, San Diego, CA; 2009. 18. Moderator, Scientific session. “2010: Transfusion-Related Acute Lung Injury” Society of Critical

Care Medicine’s 39h Critical Care Congress, 2010. 19. Chairman, Scientific Symposium. “Late Breaking Clinical Trials” American Thoracic Society

International Conference, New Orleans, LA; 2010. 20. Co-Chairman, Scientific Symposium. “Celebrating the 25th Anniversary of the National Institute of

Nursing Research” American Thoracic Society International Conference, New Orleans, LA; 2010. 21. Co-Chairman, Poster Discussion Session. “Identifying Patients at Risk of … and Rescuing Them”

American Thoracic Society International Conference, New Orleans, LA; 2010. 22. Co-Chairman, Post-Graduate Course. “Leadership Workshop: Developing Skills to advance your

career and improve your work environment” American Thoracic Society International Conference, Denver, CO; 2011.

23. Chairman, Scientific Symposium. “Late Breaking Clinical Trials” American Thoracic Society

International Conference, Denver, CO; 2011. 24. Co-Chairman, Scientific Symposium “Alcohol disorders in the Critically Ill Patient”, Der. 11

Hauptstadkongress der DGAI, Berlin, Germany, 2011 25. Co-Chairman, Post-Graduate Course. “Leadership Workshop: Developing Skills to advance your

career and improve your work environment” American Thoracic Society International Conference, San Francisco, CO; 2012.

26. Leader of Level 1. ATS MECOR course, Chennai, India; 2012.

27. Moderator, Scientific Session. “Life After the ICU: Brain and Neuromuscular Function “Society of

Critical Care Medicine’s 42h Critical Care Congress, San Juan, PR, 2013. 28. Co-Chairman, Post-Graduate Course. “Things we need to know and should have learned a long time

ago: How to build effective teams and implement change” American Thoracic Society International

Conference, Philadelphia, PA, 2013. 29. Co-Chairman, Scientific Symposium. “Psychological distress in ICU healthcare providers and the

families of our patients” American Thoracic Society International Conference, Philadelphia, PA, 2013.

30. Leader of Level 2. ATS MECOR course, Delhi, India; 2014. 31. Co-Chairman, Scientific Symposium. “Weaning from mechanical ventilation: new insights”

European Respiratory Society Conference, Amsterdam. Netherlands, 2015 32. Co-Chairman, Scientific Symposium. “Communicating with families” Critical Care Canada Forum,

Toronto, Canada; 2015. 33. Co-Chairman, Scientific Symposium. “ICU rehab and recovery” Critical Care Canada Forum,

Toronto, Canada; 2015. PUBLICATIONS 1. Khanna O, Barbieri E, Moss M, et al. Effects of calcium and verapamil on vesicourethral smooth muscle in rabbits. Urology 22: 284-290; 1983. 2. Moss M, Neff TA, Colby TV, Schwarz MI, Zamora MR. Diffuse alveolar hemorrhage due to

antibasement membrane antibody disease appearing with a polyglandular autoimmune syndrome. Chest 105: 296-298; 1994.

3. Moss M, Ackerson L, Gillespie MK, Moore FA, Moore EE, Parsons PE. Von Willebrand factor

antigen levels do not predict the development of the adult respiratory distress syndrome. Am J Respir Crit Care Med 151:15-20; 1995.

4. Moss M, Goodman P, Henig M, Barkin S, Ackerson L, Parsons PE. Establishing the relative

accuracy of three new definitions of the adult respiratory distress syndrome. Crit Care Med 23: 1629-1637; 1995.

5. Moss M, Bucher B, Moore FA, Moore EE, Parsons PE. The role of chronic alcohol abuse in the

development of acute respiratory distress syndrome in adults. JAMA 275: 50-54; 1996. 6. Moss M, Gillespie MK, Ackerson L, Moore FA, Moore EE, Parsons PE. Endothelial cell

activity varies in patients at risk for the adult respiratory distress syndrome. Crit Care Med 24: 1782-1786; 1996.

7. Connelly KG, Moss M, Parsons PE, Moore EE, Moore FA, Giclas P, Seligman P, Repine J.

Serum ferritin as a predictor of the adult respiratory distress syndrome. Am J Respir Crit Care Med 155: 21-25; 1997.

8. Parsons PE, Moss M, Gillespie MK, Moore EE, Moore FA, Repine J. IL-10 and IL-1ra

levels in patients with the acute respiratory distress syndrome. Am J Respir Crit Care Med 155: 1469-1473; 1997.

9. Holguin F, Moss M, Brown LAS, Guidot DM. Ethanol ingestion alters lung glutathione homeostasis and increases susceptibility to acute lung injury in rats. J Clin Invest 1998; 101: 761-768.

10. Moss M, Parsons PE. What is acute respiratory distress syndrome? J Intensive Care Med 1998:

13; 59-67. 11. TenHoor T, Hewan-Lowe K, Miller J, Moss M. A transitional variant of Castleman’s disease

presenting as a chylous pleural effusion. Chest 1999; 115: 285-288. 12. Moss M, Trow T, Clardy N. Differences in the response time of pages originating from the

intensive care unit. Chest 1999; 116: 1019-1024. 13. Lois M, Brown LAS, Moss M, Roman J, Guidot DM. Ethanol ingestion increases activation of

activation of matrix metalloproteinases in rat lungs during acute endotoxemia. Am J Respir Crit Care Med 1999; 160: 1354-1360.

14. Moss M, Steinberg KP, Guidot DM, Duhon GF, Treece P, Wolken R, Hudson LD, Parsons PE.

The effects of chronic alcohol abuse on the incidence of the acute respiratory distress syndrome (ARDS) and the severity of the multiple organ dysfunction syndrome (MODS) in adults with septic shock. Chest 1999: 116; 97-98S.

15. Moss M, Guidot DM, Wong-Lambertina MJ, Ten Hoor T, Perez R, Brown LAS. Glutathione

levels are decreased in the bronchoalveolar lavage fluid of chronic alcoholics. Am J Respir Crit Care Med 2000; 161: 414-419.

16. Moss M, Guidot DM, Steinberg KP, Duhon GF, Treece P, Wolken R, Hudson LD, Parsons PE.

Diabetic patients with septic shock have a decreased incidence of the acute respiratory distress syndrome (ARDS) Crit Care Med 2000; 28: 2187-2192.

17. Guidot DM, Modelska K, Lois M, Jain L, Moss M, Pittet JF, Brown LAS. Ethanol ingestion, via

glutathione depletion, impairs alveolar epithelial barrier function in rats. Am J Physiol (Lung Cell Mol. Physiol) 2000; 279: L127-L135 .

18. Maloney JP, Halbower AC, Balasubramanian V, Pike A, Fennessey P, Fouty BF, Fagan K, Moss

M. A blue-green death: systemic absorption of enteral feeding dye during critical illness. New Eng J Med 2000; 343: 1047-1048.

19. TenHoor TL, Mannino DM, Moss M. Risk factors for acute respiratory distress syndrome in the

United States: Analysis of the 1993 National Mortality Followback Study. Chest 2001; 119: 1179-1184.

20. Maloney JP, Ryan T, Brasel K, Johnson D, Morrison JL, Frankel EH, Nyffeler M, Moss M.

Food dye use in enteral feedings: A review and a call for a moratorium. Nutr Clin Practice 2002; 17: 169-181.

21. Moss M, and Mannino DM. Racial and gender differences in acute respiratory distress syndrome

(ARDS) deaths in the United States: Analysis of multiple-cause mortality data (1979-1996). Crit Care Med 2002; 30: 1679-1685.

22. Foreman M, TenHoor TL, Brown LAS, Moss M. Alterations in pulmonary glutathione homeostasis in patients with chronic liver dysfunction. Alcohol Clin: Exp Res 2002; 26: 1840-1845.

23. Moss M, Wellman DA, Cotsonis GA. An appraisal of multivariable logistic models in the

pulmonary and critical care literature. Chest 2003; 123: 923-928. 24. Moss M, Parsons PE, Steinberg KP, Hudson LD, Guidot DM, Burnham E, Eaton S, Cotsonis

GA. The effects of chronic alcohol abuse on the incidence of the acute respiratory distress syndrome (ARDS) and the severity of the multiple organ dysfunction syndrome (MODS). Crit Care Med 2003; 31: 869-877.

25. Martin GS, Mannino DM, Eaton S, Moss M. Epidemiology of sepsis in the United States:

Incidence, Demographics, and Outcome from 1979-2000. New Eng J Med 2003; 348: 1546-1554.

26. Foreman MG, Mannino DM, Moss M. Cirrhosis as a risk factor for sepsis and death: Analysis of

the National Hospital Discharge Survey. Chest 2003; 124: 1016-1020. 27. Burnham E, Brown LAS, Halls L, Moss M. Prolonged glutathione deficiency and increased total

protein concentrations in the epithelial lining fluid of chronic alcoholics. Alcohol Clin: Exp Res 2003; 27: 1167-1172.

28. Burnham EL, Moss M, Harris F, Brown LAS. Plasma and lung E-selectin levels are elevated in

ARDS patients with chronic alcohol abuse. Crit Care Med 2004; 32: 675-679. 29. Martin GS, Eaton S, Mealer M, Moss M. Extravascular lung water in patients with severe sepsis:

a prospective cohort study. Crit Care 2005; 9: 74-82. 30. Burnham EL, Taylor WR, Quyyumi AA, Rojas M, Brigham KL, Moss M. Increased circulating

endothelial progenitor cells are associated with survival in acute lung injury. Am J Respir Crit Care Med 2005; 172: 854-860.

31. Martin GS, Moss M, Wheeler AP, Mealer M, Morris JA, Bernard GR. A randomized controlled

trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med 2005; 33: 1681-1687.

32. Silverboard H, Aisiku I, Martin GS, Adams M, Rozycki G, Moss M. Association between

transfusion requirements and incidence of acute respiratory distress syndrome (ARDS) among trauma patients. J of Trauma 2005; 59: 717-723.

33. Moanna A, Flenaugh EL, Lennox JL, Moss M, Vuchetich A. Severe recurrent respiratory

papillomatosis in an HIV-infected adult on highly active antiretroviral therapy. J Bronchol 2005; 12: 210-213.

34. Martin GS, Mannino DM, Moss M. The effect of age of the epidemiology of sepsis in the

United States. Crit Care Med 2006; 34: 15-21. 35. Gao L, Grant A, Halder I, Brower R, Sevransky J, Maloney JP, Moss M, Shanholtz C, Yates CR,

Meduri GU, Shriver MD, Ingersoll R, Scott AF, Beaty TH, Moitra J, Ma SF, Ye SQ, Barnes KC,

Garcia JGN. Novel Myosin Light Chain Kinase Polymorphisms (MYLK) Confer Risk for Sepsis-Associated Acute Lung Injury. Am J Respir Cell Mol Bio 2006; 34: 487-495.

36. Danai P, Mannino DM, Moss M, Martin GS. The epidemiology of sepsis among patients with

cancer. Chest 2006; 129: 1432-40. 37. Esper AM, Mannino DM, Moss M, Martin GS. The role of infection and co-morbidity:factors

that influence disparities in sepsis. Crit Care Med 2006; 34: 2576-2582. 38. Khan J, Harrison TB, Rich MM, Moss M. Neuromuscular dysfunction in patients with severe

sepsis. Neurology 2006; 67: 1421-1425. 39. Danai P, Sinha S, Moss M, Martin GS. Seasonal variation in the incidence of sepsis. Crit Care

Med 2007; 35: 410-415. 40. Burnham EL, Moss M, Ritzenthaler JD, Roman J. Evidence for subclinical tissue remodeling

activity in lung in the setting of alcohol abuse. Alcohol Clin Exp Res 2007; 31: 675-683. 41. Mealer ML, Shelton A, Berg B, Rothbaum B, Moss M. Increased prevalence of post traumatic

stress disorder symptoms in critical care nurses. Am J Respir Crit Care Med 2007; 175: 693-697.

42. Dewit M, Bert AM, Gennings C, Burnham EL, Moss M. Alcohol use disorders increase the risk

for mechanical ventilation in medical patients. Alcohol Clin Exp Res 2007;31: 1224-1230. 43. Gao L, Flores C, Fan-Ma S, Miller EJ, Moitra J, Moreno L, Wadgaonkar R, Simon B, Brower R,

Sevransky J, Tuder RM, Maloney JP, Moss M, Shanholtz C, Yates CR, Meduri GU, Ye SQ, Barnes KC, Garcia JG. Macrophage migration inhibitory factor in acute lung injury: expression, biomarker, and associations. Transl Res 2007; 50: 18-29.

44. Gao L, Grant AV, Rafaels N, Stockton-Porter M, Watkins T, Gao P, Chi P, Munoz M, Watson H,

Dunston G, Togias A, Hansel N, Sevransky J, Maloney JP, Moss M, Shanholtz C, Brower R, Garcia JG, Grigoryev DN, Cheadle C, Beaty TH, Mathias RA, Barnes KC Polymorphisms in the myosin light chain kinase gene that confer risk of severe sepsis are associated with a lower risk of asthma. J Allergy Clin Immunol 2007; 119:1111-8.

45. Yeh MY, Burnham EL, Moss M, Brown LAS. Chronic Alcoholism Alters Systemic and

Pulmonary Glutathione Redox Status. Am J Respi Crit Care Med 2007; 176: 270-276. 46. Yeh MY, Burnham EL, Moss M, Brown LAS. Non-invasive evaluation of pulmonary glutathione

in the exhaled breath condensate of otherwise healthy alcoholics. Respir Med 2008; 102: 248-55.

47. Berkowitz DM, Danai PA, Eaton S, Moss M, Martin GS. Accurate characterization of

extravascular lung water in acute respiratory distress syndrome. Crit Care Med 2008; 36:1803-9.

48. DeWit M, Gennings C, Zilberberg M, Burnham EL, Moss M, Balster RL. Drug withdrawal,

cocaine and sedative use disorders increase the need for mechanical ventilation in medical patients. Addiction 2008; 103:1500-8.

49. Wurfel MM, Gordon AC, Holden TD, Radella F, Strout J, Kajikawa O, Ruzinski JT, Rona G, Black RA, Stratton S, Jarvik GP, Hajjar AM, Nickerson DA, Rieder M, Sevransky J, Maloney JP, Moss M, Barnes KC, Russel JA, Martin TR. Toll-like Receptor 1 Polymorphisms Affect Innate Immune Responses and Outcomes in Sepsis. Am J Respir Crit Care Med 2008; 178:710-20.

50. Robinson TN, Raeburn CD, Angles EM, Moss M. Low Tryptophan Levels Are Associated with

Post-Operative Delirium in the Elderly. Am J Surgery 2008; 196: 670-74. 51. Angles EM, Robinson TN, Biffl WL, Johnson J, Moss M, Tran ZV, Moore EE. Risk Factors for

Delirium Following Major Trauma. Am J Surgery 2008; 196: 864-70. 52. Burnham EL, Halkar R, Burks M, Moss M. The Effects of Alcohol Abuse on Pulmonary

Alveolar-Capillary Barrier Function in Humans. Alcohol Alcohol 2009; 44: 8-12. 53. Hodgin K, Nordon-Craft A, McFann K, Mealer M, Moss M. Physical Therapy Utilization in

Intensive Care Units: Results from a National Survey. Crit Care Med 2009; 37: 561-568. 54. Robinson TN, Raeburn CD, Tran ZV, Angles EM, Brenner LA, Moss M. Post-Operative

Delirium in the Elderly – Risk Factors and Outcomes. Ann of Surgery 2009; 249: 173-178. 55. Esper A, Moss M, Martin GS. The effect of diabetes mellitus on organ dysfunction with sepsis:

an epidemiological study. Crit Care 2009: 13: 1-6. 56. Berkowitz DM, Danai PA, Eaton S, Moss M, Martin GS. Alcohol abuse enhances pulmonary

edema in acute respiratory distress syndrome. Alcohol Clin Exp Res 2009; 33: 1-7. 57. Mealer M, Burnham EL, Goode CJ, Rothbaum B, Moss M. The prevalence and impact of post

traumatic stress disorder and burnout syndrome in nurses. Depression and Anxiety 2009; 26:1118-26.

58. Robinson TN, Eiseman B, Wallace JI, Church SD, McFann KK, Pfister SM, Sharp TJ, Moss M.

Redefining geriatric preoperative assessment using frailty, disability and co-morbidity. Ann Surg 2009; 25: 449-55.

59. Huie TJ, Olson AL, Cosgrove GP, Janssen WJ, Lara AR, Lynch DA, Groshong SD, Moss M,

Schwarz MI, Brown KK, Frankel SK. A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: Aetiology and outcomes. Respirology 2010;15:909-17.

60. Burnham EL, Mealer M, Gaydos J, Majka S, Moss M. The presence of acute lung injury but not

severe sepsis increases colony formation by circulating peripheral blood mononuclear cells. Am J Respir Cell Mol Biol 2010; 43:326-33.

61. Bull T, Clark B, McFann K, Moss M. Pulmonary vascular dysfunction is associated with poor

outcomes in patients with acute lung injury. Am J Respir Crit Care Med 2010;182:1123-1128. 62. Benson AB, Austin G, McFann K, Silliman C, Moss M. Transfusion-related acute lung injury in

ICU patients admitted with gastrointestinal bleeding. Intensive Care Med. 2010;36:1710-7.

63. Boe D, Richens T, Horstmann S, Janssen WJ, Henson PM, Moss M, Vandivier RW. Acute and chronic alcohol exposure impair the phagocytosis of apoptotic cells and enhance the pulmonary inflammatory response. Alcohol Clin Exp Res. 2010;34: 1723-32.

64. Benson AB, Burton JR, Austin GL, Biggins SW, Zimmerman MA, Kam I, Mandell S, Silliman

CC, Rosen H, Moss M. Differential effect of transfusion on acute lung injury and infection risk following liver transplantation. Liver Transpl 2011; 17: 149-158.

65. Burnham EL, Phang TL, House R, Vandivier RW, Moss M, Gaydos J. Alveolar macrophage

gene expression is altered in the setting of alcohol use disorders. Alcohol Clin Exp Res. 2011;35:284-94.

66. Nordon-Craft A, Schenkman M, Ridgeway K, Benson A, Moss M. Physical Therapy

Management and Patient Outcomes following ICU-Acquired Weakness: A Case Series. J Neurol Phys Ther. 2011; 35:133-40.

67. Czaja AS, Moss M, Mealer M. Post traumatic stress disorder (PTSD) among pediatric acute care

nurses. J Pediatr Nurs 2012 27: 357-365. 68. Robinson TN, Wallace JI, Wu DS, Wiktor A, Pointer LF, Pfister SM, Sharp TJ, Buckley MJ,

Moss M. Accumulated Frailty Characteristics Predict Postoperative Discharge Institutionalization in the Geriatric Patient. J Am Coll Surg. 2011 Mar 22

69. Robinson TN, Raeburn CD, Tran ZV, Brenner LA, Moss M. Motor subtypes of postoperative

delirium in older adults. Arch Surg. 2011;146:295-300. 70. Paine R, Standiford TJ, Dechert RE, Moss M, Martin GS, Rosenberg, AL, Thannickal VJ,

Burnham EL, Brown MB, Hyzy RC. A randomized trial of recombinant human GM-CSF for patients with acute lung injury. Crit Care Med 2012: 40: 90-97.

71. Malcolm KC, Kret JE, Young RL, Poch KP, Douglas IS, Coldren CD, Burnham EL, Moss M,

Nick JA. Interferon-Stimulated Gene Expression Is Associated With Gram-Positive-Specific Neutrophil Dysfunction In The Acute Respiratory Distress Syndrome. PLOS One 2011; 6:e21958.

72. Matthay MA, Brower RG, Carson S, Douglas IS, Eisner M, Hite D, Holets S, Kallet RH, Liu

KD, Macintyre N, Moss M, Schoenfeld D, Steingrub J, Thompson BT; The National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Randomized, Placebo-Controlled Clinical Trial of an Aerosolized Beta-2 Agonist for Treatment of Acute Lung Injury. Am J Respir Crit Care Med. 2011;184:561-8.

73. Shea JA, Stern DT, Klotman PE, Clayton CP, O'Hara JL, Feldman MD, Griendling KK, Moss M,

Straus SE, Jagsi R. Career Development of Physician Scientists: A Survey of Leaders in Academic Medicine. Am J Med. 2011;124:779-87.

74. Clark BJ, Smart A, Douglas I, House R, Burnham EL, Moss M. Severity of acute illness is

associated with baseline readiness to change in medical intensive care unit patients with unhealthy alcohol use. Alcohol Clin Exp Res. 2012: 36; 544-551.

75. Mealer M, Jones J, Newman J, McFann K, Rothbaum B, Moss M. The presence of resilience is associated with a healthier psychological profile in ICU nurses: Results of a national survey. Int J Nurs Stud. 2012; 49:292-9.

76. Robinson TN, Wu DS, Stiegmann GV, Moss M. Frailty predicts increased hospital and six-

month healthcare cost following colorectal surgery in older adults. Am J Surg. 2011; 202: 511-514.

77. Macht M, Wimbish T, Clark BJ, Benson AB, Burnham EL, Williams A, Moss M. Post-

extubation dysphagia is persistent and associated with poor outcomes in survivors of critical illness. Crit Care. 2011; 15:R231.

78. Burnham EL, McCord JM, Bose S, Brown LA, House R, Moss M, Gaydos J. Protandim(R) does

not influence alveolar epithelial permeability or intrapulmonary oxidative stress in human subjects with alcohol use disorders. Am J Physiol Lung Cell Mol Physiol 2012; ;302:L688-99.

79. Rice TW, Wheeler AP, Thompson BT, Steingrub J, Hite RD, Moss M, Morris A, Dong N, Rock

P. Initial trophic vs. full enteral feeding in patients with acute lung injury: the EDEN randomized trial. JAMA 2012; 307; 795-803.

80. Newman J, Smart A, Reese T, Williams A, Moss M. Surrogate and Patient Discrepancy Regarding Consent for Critical Care Research. Crit Care Med 2012;40:2590-4.

81. Mealer M, Jones J, MossM. A qualitative study of resilience and posttraumatic stress disorder in

US ICU nurses. Int Care Med 2012;38:1445-51. 82. Robinson TN, Wu DS, Pointer LF, Dunn CL, Moss M. Preoperative cognitive dysfunction is

related to adverse postoperative outcomes in the elderly. J Am Coll Surg 2012; 215:12-7. 83. Finigan JH, Mishra R, Vasu VT, Silveira LJ, Nethery DE, Standiford TJ, Burnham EL, Moss M,

Kern JA. BAL neuregulin-1 is elevated in acute lung injury and correlates with inflammation. Eur Respir J 2013; 41: 396-401.

84. Macht M, Wimbish T, Clark BJ, Benson AB, Burnham EL, Williams A, Moss M. Diagnosis and

treatment of post-extubation dysphagia: Results from a national survey. J Crit Care 2012; 27:578-86.

85. Clark BJ, Williams A, Cecere LM, Bradley KA, Macht M, Moss M, Burnham EL. Alcohol

Screening Scores and 90 Day Outcomes in Patients with Acute Lung Injury. Crit Care Med 2013; 41: 1518-1525.

86. Burnham EL, Hyzy RC, Paine R 3rd, Coley C 2nd, Kelly AM, Quint LE, Lynch D,

Janssen WJ, Moss M, Standiford TJ. Chest Computed Tomography Features Are Associated With Poorer Quality of Life in Acute Lung Injury Survivors. Crit Care Med 2013; 41: 445-456.

87. Clark BJ, Keniston A, Douglas IS, Beresford T, Macht M, Williams A, Jones J, Burnham

EL, Moss M. Healthcare Utilization in Medical Intensive Care Unit Survivors with Alcohol Withdrawal. Alcohol Clin Exp Res 2013; 37: 1536-1543.

88. Clark BJ, Bull TM, Benson AB, Stream AR, Macht M, Gaydos J, Meadows C, Burnham EL, Moss M. Growth differentiation factor-15 and prognosis in acute respiratory distress syndrome: a retrospective cohort study. Crit Care 2013: 17: R92

89. Robinson TN, Wu DS, Sauaia A, Dunn CL, Stevens-Lapsley JE, Moss M, Stiegmann GV,

Gajdos C, Cleveland JC Jr, Inouye SK. Slower Walking Speed Forecasts Increased Postoperative Morbidity and 1-Year Mortality across Surgical Specialties. Ann Surg. 2013; 258: 582-90.

90. Macht M, King CJ, Wimbish T, Clark BJ, Benson AB, Burnham EL, Williams A, Moss M. Post-

extubation dysphagia is associated with longer hospitalization in survivors of critical illness with neurologic impairment. Crit Care 2013: 17: R119.

91. Clark BJ, Jones J, Cook P, Tain K, Moss M. Facilitators and barriers to initiating change in

medical intensive care unit survivors with alcohol use disorders: A qualitative study. J Crit Care 2013; 28: 849-856.

92. Ginde AA, Moss M, Shapiro NI, Schwartz RS. Impact of older age and nursing home residence

on clinical outcomes of US emergency department visits for severe sepsis. J Crit Care 2013; 28: 606-611.

93. Smart A, Thompson BT, Needham DM, Hopkins RO, Williams A, Burnham EL, Moss M.

Surrogate consent for genetic testing, the reconsent process, and consent for long term outcomes in ARDS trials. Am J Respir Crit Care Med 2013; 188: 1370-1373.

94. Robinson TN, Wu DS, Pointer L, Dunn CL, Cleveland JC, Moss M. Simple frailty score predicts

postoperative complications across surgical specialties. Am J Surg 2013; 206: 544-550. 95. Mealer M, Kittelson J, Thompson BT, Wheeler AP, Magee JC, Sokol RJ, Moss M, Kahn MG.

Remote source document verification in two national clinical trials networks: a pilot study. PloS One 2013; 8: e81890.

96. Kiser TH, Allen RR, Valuck RJ, Moss M, Vandivier RW. Outcomes Associated with

Corticosteroid Dosage in Critically Ill Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2014; 189: 1052-1064.

97. Moss M, Yang M, Macht M, Sottile P, Gray L, McNulty M, Quan D. Screening for critical

illness polyneuromyopathy with single nerve conduction studies. Intensive Care Med 2014; 40: 683-690.

98. Burnham EL, Hyzy RC, Paine R 3rd, Kelly AM, Quint LE, Lynch D, Curran-Everett D, Moss M,

Standiford TJ. Detection of Fibroproliferation by Chest High Resolution Computed Tomography in Resolving Acute Respiratory Distress Syndrome. Chest 2014; 146: 1196-1204.

99. Fernandez-Bustamante A, Klawitter J, Repine JE, Agazio A, Janocha AJ, Shah C, Moss M,

Douglas IS, Tran ZV, Erzurum SC, Christians U, Seres T. Early Effect of Tidal Volume on Lung Injury Biomarkers in Surgical Patients with Healthy Lungs. Anesthesiology 2014; 121: 469-481.

100. Nordon-Craft A, Schenkman M, Edbrooke L, Malone DJ, Nordon-Craft A, Schenkman M,

Edbrooke L, Malone DJ, Moss M, Denehy L. The Physical Function Intensive Care Test: Implementation in Survivors of Critical Illness. Phys Ther 2014; 94: 1499-1507.

101. Robinson TN, Dunn CL, Adams JC, Hawkins CL, Tran ZV, Raeburn CD, Moss M. Tryptophan Supplementation and Postoperative Delirium: A randomized controlled trial. J Am Geriatr Soc 2014; 62: 1764-1771.

102. Denehy L, Nordon-Craft A, Edbrooke L, Malone D, Berney S, Schenkman M, Moss M. Outcome

measures report different aspects of patient function three months following critical care. Int Care Med 2014; 40: 1862-1869.

103. Mealer M, Conrad D, Evans J, Jooste K, Solyntjes J, Rothbaum B, Moss M. Feasibility and

acceptability of a resilience training program for intensive care nurses. Am J Crit Care 2014; 23: e97-e105.

104. Sottile PD, Nordon-Craft A, Malone D, Luby D, Schenkman M, Moss M. Physical Therapist

Treatment of Patients in the Neurological Intensive Care Unit: Description of Practice. Phys Ther. 2015; 95: 1006-1014.

105. Reisinger MW, Moss M, Clark BJ. Brief Versus Full Alcohol Use Disorders Identification Test

in National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network Clinical Trials. Crit Care Med 2015; 43: 382-385.

106. Malone D, Ridgeway K, Nordon-Craft A, Moss P, Schenkman M, Moss M. Physical Therapist

Practice in the Intensive Care Unit: Results of a National Survey. Phys Ther. 2015; 9:1335-44. 107. Sottile PD, Nordon-Craft A, Malone D, Schenkman M, Moss M. Patient and family perceptions

of physical therapy in the medical intensive care unit. J Crit Care. 2015; 30: 891-895. 108. Moss M, Nordon-Craft A, Malone D, Van Pelt D, Frankel SK, Warner ML, Kriekels W,

McNulty M, Fairclough D, Schenkman M. A randomized trial of an intensive physical therapy program for acute respiratory failure patients. Am J Respir Crit Care Med 2016 (in press).

109. Brown SM, Grissom CK, Moss M, Rice TW, Schoenfeld D, Hou P, Thompson BT, Brower RG.

Non-linear imputation of Pao2/Fi02 from Sp02/Fi02 among patients with acute respiratory distress syndrome. Chest 2016 (in press).

110. Clark BJ, Rubinsky AD, Ho PM, Au DH, Chavez LJ, Moss M, Bradley KA. Alcohol screening

scores and the risk of intensive care unit admissions and hospital readmission. Subst Abuse 2016 (in press).

CHAPTERS AND REVIEWS 1. Moss M, and Make BJ. Pulmonary response to exercise in health and disease. Sem Respir Med

14: 106-120; 1993. 2. Moss M. Pulmonary embolism. in: Case Oriented Problems in Internal Medicine. RW

Schrier (ed), Little Brown Co. 1994. 3. Moss M, and Parsons PE. Mechanical ventilation in the adult respiratory distress syndrome.

Sem Respir Med 15: 289-299; 1994. 4. Parsons PE, and Moss M. Early detection and markers of sepsis. Clinics in Chest Med 17: 1 99-212; 1996.

5. Moss M. Adult respiratory distress syndrome. in: Pulmonary Secrets. PE Parsons and JE

Heffner (First edition), Hanley & Belfus. 1996. 6. Moss M. Clincal Checklist: The acute respiratory distress syndrome. Cortlandt Forum 10: 217-227; 1997. 7. Parsons PE, and Moss M. Circulating markers of sepsis and acute lung injury. in: Textbook of

Sepsis and Multiorgan Failure. AM Fein, E Abraham, R Balk, G Bernard, RC Bone, D Dantzker, M Fink (ed), Williams & Wilkens. 1997.

8. Moss M. Venous Thromboembolism. in: Critical Care Secrets. PE Parsons and J Wiener-

Kronish (ed), Hanley & Belfus. 1998. 9. Moss M, and Ingram R. Acute respiratory distress syndrome. in: Harrison’s Principles of

Internal Medicine. Braunwald, Fauci, Kasper, Hauser, Longo, Jameson (eds) 15th edition. 2001.

10. Moss M. The role of alcohol in severe pneumonia and acute lung injury. in: Perspectives on

Critical Care Infectious Disease. Rello and Leeper (ed), Kluwer Academic. 2001. 11. Moss M, and Ingram R. Acute respiratory failure. in: Scientific American Medicine. Dale DC

and Federman DD (ed). 2001. 12. Eaton S, and Moss M. Adult respiratory distress syndrome. in: Pulmonary Secrets. PE Parsons

and JE Heffner (Second edition), Hanley & Belfus. 2001. 13. Foreman M, and Moss M. The role of hepatic dysfunction in critical illness. Pulmonary

Perspectives 18: 8-9; 2001. 14. Guidot DM, Moss M, and Brown LS. Ethanol ingestion, via glutathione depletion, impairs

alveolar epithelial function and renders the lung susceptible to acute injury during oxidative stress. Etiology and Treatment of Acute Lung Injury: From bench to bedside. Matalon, S. and Sznajder, J.I. ed. Volume 336 in the NATO Science Series. IOS Press, Amsterdam/Berlin/ Oxford/Tokyo/Washington, D.C. 2001.

15. Burnham E, Guidot DM, Brown LAS, Moss M. Alcohol, Sepsis, and ARDS. Advances in

Sepsis 1: 125-131, 2002. 16. Foreman M, and Moss M. Venous Thromboembolism. in: Critical Care Secrets. PE Parsons

and J Wiener-Kronish (2nd ed), Hanley & Belfus. 2002. 17. Moss M, and Thompson T. Definitions and clinical risk factors. In: Acute Respiratory

Distress Syndrome: Lung Biology and Health and Disease Series. M. Matthay (ed), Marcel Dekker. Volume 179, 2003.

18. Burnham EL, Moss M, Martin GS. The effect of alcohol consumption on risk for sepsis and

ARDS. In: 23rd ISICEM Yearbook. pages 86-95, 2003. 19. Moss M, Burnham EL. Chronic alcohol abuse, ARDS, and multiple organ dysfunction. Crit

Care Med 2003; 31: S207-212.

20. Silverboard H, Martin GS, Moss M. ARDS: Diagnosis and clinical presentation. J Respir Dis

2003; 24: 340-348. 21. Leeper KV, and Moss M. Bacterial Pneumonia. In: Current Diagnosis and Treatment in

Pulmonary Disease. Hanley M and Welsh C. (eds), McGraw-Hill, 2003. 22. Burnham EL, Moss M, Ziegler TR. Myopathies in critical illness: characterization and

nutritional aspects. J Nutrition 2005; 135: 1818S-1823S. 23. Moss M. Epidemiology of Sepsis: Race, Gender, and Alcohol Abuse. Clin Inf Dis 2005; 41:

S490-497. 24. Burnham EL, and Moss M. Adult respiratory distress syndrome. in: Pulmonary Secrets. PE

Parsons and JE Heffner (Third edition), Hanley & Belfus. 2006. 25. Danai P, and Moss M. Venous Thromboembolism. in: Critical Care Secrets. PE Parsons and J

Wiener-Kronish (3nd ed), Hanley & Belfus. 2006. 26. Moss M, and Burnham EL. Alcohol abuse and the critically ill patient. Lancet 2006; 368: 2231-

2242. 27. Khan J, Burnham EL, Moss M. Acquired weakness in the ICU: critical illness myopathy and

polyneuropathy. Minerva Anestesiologica 2006; 72: 401-406 28. Burnham EL, Moss M. Progenitor cells in acute lung injury. Minerva Anestesiologica 2006;

72: 369-374. 29. Esper A, Burnham EL, Moss M. The effect of alcohol abuse on ARDS and multiple organ

dysfunction. Minerva Anestesiologica 2006; 72: 375-382. 30. Moss M. Clinical Year in Review III: Critical care, mechanical ventilation, sleep medicine, and

lung cancer. Proc Am Thorac Soc 2006; 3: 645-649. 31. Moss M. Clinical Year in Review II: Interstitial lung disease, sepsis, pulmonary infections, and

sleep medicine. Proc Am Thorac Soc 2007; 4: 482-488. 32. Tino G, Ware LB, Moss M. Clinical Year in Review IV: Chronic obstructive pulmonary

disease, nonpulmonary critical care, diagnostic imaging, and mycobacterial disease. Proc Am Thorac Soc 2007; 4: 494-498.

33. Deja M, Hommel M, Weber-Carstens S, Moss M, von Dossow V, Sander M, Pille C, Spies C.

Evidence-based therapy of severe acute respiratory distress syndrome: an algorithm-guided approach. J Int Med Res 2008; 36: 211-21.

34. Moss M, and Thompson T. Definitions and clinical risk factors. In: Acute Respiratory

Distress Syndrome: Lung Biology and Health and Disease Series. A Choi (ed), Informa Healthcare, 2009.

35. Moss M. Clinical Year in Review I: Lung cancer, pleural disease, exercise testing/pulmonary

rehabilitation, and sleep medicine. Proc Am Thorac Soc 2008; 5: 739-744

36. Moss M, Wilkes D, Ware L. Clinical Year in Review II: Pulmonary infections in the

immnocompetent host, issues in the training of fellows and residents, asthma, and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5: 745-750.

37. Hodgin K, Moss M. The epidemiology of sepsis. In: Sepsis: Current Pharmaceutical Design.

T Standiford and M Moss (eds), 2008; 14: 1833-9. 38. Hodgin K, MossM. ARDS (Acute Respiratory Distress Syndrome). In: Oxford Handbook of

Pulmonary Medicine. KK Brown (ed), Oxford University Press, Oxford, 2009. 39. Boe D, Moss M. Unexplained respiratory failure. In: Oxford Handbook of Pulmonary

Medicine. KK Brown (ed), Oxford University Press, Oxford, 2009. 40. Reynolds SD, Henson PM, Downey GP, Moss M. Injury and Repair of the Lung. In: Murray

and Nadel’s Textbook of Respiratory Medicine. Mason RJ, Broaddus VC, Murray JF, and Nadel JA (eds), (in press).

41. Benson AB, Moss M, Silliman CC. Transfusion-related acute lung injury (TRALI): a clinical

review with emphasis on the critically ill. Br J Haematol 2009; 147: 431-43. 42. Boé DM, Vandivier RW, Burnham EL, Moss M. Alcohol abuse and pulmonary disease. J

Leukoc Biol 2009 Nov; 86:1097-104. 43. Burnham EL, Majka S, Moss M. Role of progenitor cells in lung disease prognosis. In: Stem

Cell and the Respiratory System. M Rojas (ed), Humana Press, New York, 2010. 44. Clark BJ, Moss M. Secondary prevention in the intensive care unit: Does intensive care unit

admission represent a “teachable moment?” Crit Care Med 2011; 39: 1500-1506. 45. Nordon-Craft A, Moss M, Quan D, Schenkman M. ICU-Acquired Weakness – Clinical

Perspectives. Phys Ther 2012: 92: 1494-1506. 46. Lieu TA, Au D, Krishnan JA, Moss M, Selker H, Harabin A, Taggart V, Connors A..

Comparative Effectiveness Research in Lung Diseases and Sleep Disorders: Recommendations from the NHLBI Workshop. Am J Respir Crit Care Med. 2011;184:848-56.

47. Macht M, and Moss M. Venous Thromboembolism. in: Critical Care Secrets. PE Parsons and

J Wiener-Kronish (4th ed), Hanley & Belfus. 2011. 48. Burnham EL, Janssen WJ, Riches DW, Moss M, Downey GP. The Fibroproliferative Response

in ARDS: Mechanisms and Clinical Significance. Eur Respir J 2013; (accepted). 49. Thompson BT, and Moss M. A new definition of the acute respiratory distress syndrome. Sem

Respir Med 2013: 34: 441-447. 50. Macht M, Wimbish T, Bodine C, Moss M. ICU-Acquired swallowing disorders. Crit Care

Med 2013; 41: 2396-2405.

51. Sottile PD, Moss M, Patel JJ, Truwit JD, Sheikh M, Zimmerman JL, Diwakar A, Schmidt GA, Means GT, Katz JN, Desai AS, MacIntyre NR, Poston JT. ATS Core Curriculum 2014: Part II. Adult Critical Care Medicine. Ann Am Thorac Soc. 2014;11:1307-1315.

52. Macht M, White D, Moss M. Swallowing Dysfunction in critical illness. Chest 2014; 146:

1681-1689. 53. Fan E, Cheek F, Chlan L, Gosselink R, Hart N, Herridge MS, Hopkins RO, Hough CL, Kress

JP, Latronico N, Moss M, Needham DM, Rich MM, Stevens RD, Wilson KC, Winkelman C, Zochodne DW, Ali NA. An official American Thoracic Society Clinical Practice guideline: the diagnosis of intensive care unit-acquired weakness in adults. Am J Respir Crit Care Med 2014;190:1437-46.

54. Riches DW, Burnham EL, Moss M, Downey GP, Schmidt EP. Introduction to the 57th annual Thomas L. Petty Aspen Lung Conference: Rebuilding the injured lung. Ann Am Thorac Soc. 2015; 12: S1-2.

55. Evans J, Mealer M, Jooste K, Moss M. Expressive Writing for Caregiver Resilience: A

Research Perspective. in Expressive Writing: Counseling and Healthcare (ed) Thompson K and Adams K.; Rowman and Littlefield Publishing, 2015.

56. Nearing KA, Hunt C, Presley JH, Nuechterlein BM, Moss M, Manson SM. Solving the Puzzle

of Recruitment and Retention-Strategies for Building a Robust Clinical and Translational Research Workforce. Clin Transl Sci. 2015; 8: 563-7.

57. Manson SM, Martinez DF, Buchwald DS, Rubio DM, Moss M. Vision, Identity, and Career in

the Clinical and Translational Sciences: Building upon the Formative Years. Clin Transl Sci. 2015; 8:568-72.

58. Guerin C, Moss M, Talmor D. A glossary of ARDS for beginners. Int Care Med 2016 (in

press) INVITED EDITORIALS 1. Burnham E, and Moss M. A potential new therapy for sepsis: Learning from prior experience.

Crit Care Med. 2001; 29: 690-691. 2. Martin GS, and Moss M. The crystal ball for ALI prognosis: filled with surfactant? Crit Care

Med 2003; 31: 311-313. 3. Moss M, and Martin GS. A global perspective on the epidemiology of sepsis. Int Care Med

2004: 30; 527-529. 4. Moss M. Biomarkers in acute lung injury: a search for the holy grail. Int Care Med 2006; 32:

1112-1113. 5. Standiford T, Moss M. Sepsis: evolving concepts and therapeutic strategies. In: Sepsis: Current Pharmaceutical Design. T Standiford and M Moss (eds), 2008; 14: 1833-9. 6. Benson AB, and Moss M. Trauma and ARDS: Weighing the risks and benefits of blood transfusion. Anesthesiology 2009; 110: 216-7.

7. Burnham E, Moss M, Geraci MW. The case for 24/7 in-house intensivist coverage. Am J Respir Crit Care Med 2010; 181: 1159-1160. 8. Huie T, Moss M, Frankel S. What can biomarkers tell us about the pathogenesis of acute exacerbations of idiopathic pulmonary fibrosis? Am J Physiol Lung Cell Mol Physiol. 2010; 299:L1-2. 9. Moss M, and Standiford TS. Leptin in Fibroproliferative ARDS: Not just a Satiety Factor. Am J Respir Crit Care Med 2011;183:1443-4: 10. Moss M, and Au D. ATS International Conference Preview: Where Today’s Science Will Meet Tomorrow’s Care. Am J Respir Crit Care Med 2011; 183: 1117-1118. 11. Azoulay E and Moss M. Embracing physical and neuropsychological dysfunction in acute lung

injury survivors: the time has come. Am J Respir Crit Care Med 2012; 185: 470-471. 12. Ginde A, and Moss M. Has the time for advanced prehospital care of severe sepsis finally

arrived? Am J Respir Crit Care Med 2012; 186: 1204-1205. 13. Frankel SK, and Moss M. The effect of organizational structure and processes of care on ICU

mortality as revealed by the USCIITG-Critical illness outcomes study. Crit Care Med 2014: 42: 463-464.

14. Esper A, and Moss M. Diabetes and ARDS: Can we finally believe the epidemiology? Crit Care

Med 2013; 41: 2822-2823. 15. Ginde AA, and Moss M. Lung protective ventilation in emergency department patients with

severe sepsis (letter). Acad Emerg Med 2014; 21: 96-97. 16. Clark BJ, Binswanger IA, Moss M. The intoxicated ICU patient: another opportunity to improve

long-term outcome. Crit Care Med 2014; 42: 1563-1564. 17. Moss M. Pro-con debate: Mortality is the only accepted outcome in ARDS. Intens Care Med

2015; 41: 141-143. 18. Neumeier AT, Moss M. We Need an Additional Seat at the Critical Care Multidisciplinary Team

Table for our Speech-Language Pathologists. Ann Am Thorac Soc 2014; 10: 1610-1611. 19. Clark BJ, Moss M. The Acute Respiratory Distress Syndrome: Dialing in the Evidence? JAMA

2016: 315: 759-761. ABSTRACTS (1997-2015) 1. Wong-Lambertina MJ, Brown LAS, Perez R, Guidot DM, Moss M. Glutathione levels are

decreased in the Bronchoalveolar Lavage Fluid of Chronic Alcoholics. Am J Respir Crit Care Med 155; A391, 1997.

2. M Moss, T Trow, N Clardy. The response time for ICU pages is influenced by the type of paging

system. Am J Respir Crit Care Med 157; A754, 1998.

3. TL TenHoor, DM Mannino, DM Guidot, M Moss Alcohol consumption of greater than three

times per week is associated with an increased proportionate mortality ratio from the acute respiratory distress syndrome (ARDS). Am J Respir Crit Care Med 159; A717, 1999.

4. TL TenHoor, LAS Brown, DM Guidot, M Moss. Glutathione levels are decreased in the alveolar

lining fluid of the lung from patients with cirrhosis. Am J Respir Crit Care Med 159; A376, 1999.

5. DA Wellman, GA Cotsonis, M Moss. A critical appraisal of the use of multivariate logistic

regression analysis in the pulmonary and critical care literature (1997-1998). Am J Respir Crit Care Med 161; A906, 2000.

6. Eaton S, Burnham E, Steinberg KP, Hudson LD, Parsons, PE, Moss M. Direct Lung Injury is

Associated with an Increased Incidence of the Acute Respiratory Distress Syndrome in Septic Patients. Am J Respir Crit Care Med 163; A448, 2001.

7. Burnham E, Brown LAS, Eaton S, Moss M. Prolonged Glutathione Deficiency and Increased

Total Protein Concentrations in the Epithelial Lining Fluid of Chronic Alcoholics. Am J Respir Crit Care Med 163; A816, 2001.

8. Burnham EL, Steinberg KP, Haber MJ, Hudson LD, Parsons PE, Moss M. Duration of

mechanical ventilation and length of stay are increased in ARDS survivors with a history of alcohol abuse. Am J Respir Crit Care Med 165; A219, 2002.

9. Burnham EL, Eaton S, Moss M. The positive predictive value of ICD-9 codes for the diagnosis

of acute lung injury. Am J Respir Crit Care Med 165; A220, 2002. 10. Martin GS, Mannino DM, Moss M. Sepsis, organ failure, and mortality in the United States. Am

J Respir Crit Care Med 165; A471, 2002. 11. Martin GS, Mannino DM, Moss M. Epidemiologic shifts in sepsis in the United States, 1979-

1999. Am J Respir Crit Care Med 165; A471, 2002. 12. Foreman MG, Mannino DM, Moss M. Hospitalized patients with cirrhosis are at increased risk

of sepsis and death. Am J Respir Crit Care Med 165; A471, 2002. 13. Eaton S, Burnham EL, Martin GS, Moss M. The ICD-9 code for septicemia maintains a high

positive predictive value for clinical sepsis. Am J Respir Crit Care Med 165; A471, 2002. 14. Burnham EL, Harris F, Moss M, Brown LAS. Plasma and lung E-selectin levels are elevated in

ARDS patients with chronic alcohol abuse. Am J Respir Crit Care Med 165; A476, 2002. 15. Eaton S, Moss M, Martin GS. Extravascular lung water correlates with oxygenation and lung

injury in patients with severe sepsis. Am J Respir Crit Care Med 165; A712, 2002. 16. Kershaw C, Martin GS, Moss M. Patient and family member agreement on the alcohol history of

ICU patients. Am J Respir Crit Care Med 167; A251, 2003. 17. Martin GS, Mannino DM, Moss M. The effect of cancer on risks and outcomes in sepsis. Am J

Respir Crit Care Med 167; A549, 2003.

18. Burnham EL, Moss M, Patel H, Brown LAS. Epithelial lining fluid (ELF) hydrogen peroxide is

elevated in subjects with a history of chronic alcohol abuse. Am J Respir Crit Care Med 167; A661, 2003.

19. Silverboard HP, Adams MR, Moss M. Health related quality (HRQoL) and neurocognitive

function may be overestimated in survivors of acute respiratory distress syndrome. Am J Respir Crit Care Med 167; A738, 2003.

20. Silverboard HP, Aisiku I, Adams MR, Martin GS, Rozycki GS, Moss M. Transfusion

requirements among trauma patients and the incidence of acute respiratory distress syndrome (ARDS). Am J Respir Crit Care Med 167; A740, 2003.

21. Martin GS, Mannino DM, Moss M. Effect of age on the development and outcome with sepsis.

Am J Respir Crit Care Med 167; A837, 2003. 22. Martin GS, Moss M, Wheeler AP, Bernard GR. The addition of albumin to furosemide therapy

improves oxygenation in hypoproteinemic ALI. Am J Respir Crit Care Med 169; A256, 2004. 23. Esper AM, Lewis CA, Nisbet R, Mannino DM, Moss M, Martin GS. Gender disparities in the

incidence and outcome of sepsis according to source. Am J Respir Crit Care Med 169; A634, 2004.

24. Nisbet R, Lewis CA, Esper AM, Mannino DM, Moss M, Martin GS. Racial disparities in

incidence and outcome of sepsis according to source. Am J Respir Crit Care Med 169; A635, 2004.

25. Burnham EL, Taylor WR. Brigham KL, Moss M. Endothelial cell progenitor cells are associated

with improved survival in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 169; A781, 2004.

26. Burnham EL, Rojas M, Woods C, Brown LAS, Moss M. Colony stimulating factors and outcome

in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 169; A781, 2004.

27. Khan J, Rich M, Burnham EL, Moss M. The development of neuromuscular dysfunction in

patients with severe sepsis. Am J Respir Crit Care Med 169; A783, 2004. 28. Munoz M, Zhang S, Grant A, Meduri GU, Yates CR, Moss M, Maloney J, Sevransky J,

Shanholtz C, Beaty T, Brower B, Garcia JGN, Barnes KC. Variants in the plasminogen activator inhibitor gene and sepsis-assocaited acute lung injury. Proceeding of the ATS 2; A147, 2005.

29. Gao L, Grant A, Zhang S, Sevransky J, Shanholtz C, Maloney J, Moss M, Yates CR, Meduri GU,

Beaty T, Garcia JGN, Barnes KC. Sincle nucleotide polymorphisms in the gene encoding acyloxyacyl hydrolase (AOAH) and a potential role in sepsis-assocaited acute lung injury. Proceeding of the ATS 2; A151, 2005.

30. Lewis CA, Moss M, Martin GS. Temporal epidemiology of severe sepsis in the United States:

1979-2002. Proceeding of the ATS 2; A152, 2005.

31. Sinha S, Martin GS, Moss M. Seasonal variability in the incidence and outcome of sepsis and severe sepsis in the United States. Proceeding of the ATS 2; A153, 2005.

32. Yeh MY, Burnham EL, Mealer ML, Moss M, Wong M, Brown LS. Markers of oxidant stress

and injury in the exhaled breath condensate of trauma patients. Proceeding of the ATS 2; A379, 2005.

33. Burnham EL, Yeh M, Mealer ML, Brown LAS, Moss M. Decreased exhaled breath condensate

pH is associated with a poor outcome in patients with severe trauma. Proceeding of the ATS 2; A430, 2005.

34. Khan J, Harrison TB, Mealer ML, Rich MM, Moss M. Abnormalities on electromyography are

associated with reduced health related quality of life in ARDS survivors. Proceeding of the ATS 2; A434, 2005.

35. Burnham EL, Ritzenthaler JD, Moss M, Roman J. Fibronectin gene transcription is increased in

individuals with a history of chronic alcohol abuse. Proceeding of the ATS 2; A840, 2005. 36. Khan J, Harrison T, Rich M, Moss M. Changes on serial nerve conduction studies accurately

predict the development of intensive care (ICU) acquired paresis in patients with severe sepsis. Proceeding of the ATS 3; A138, 2006.

37. Burnham EL, Rojas M, Taylor WR, Moss M. The number of circulating endothelial progenitor

cells in ARDS patients is independent of serum growth factor concentrations. Proceeding of the ATS 3; A203, 2006.

38. Burnham EL, Ritzenthaler J, Moss M, Roman J. Alveolar macrophage fibronectin mRNA

transcription is augmented in chronic alcohol abuse. Proceeding of the ATS 3; A205, 2006. 39. Yeh MY, Burnham EL, Moss M, Sisson JH, Brown LAS. Monitoring of the bronchoalveolar

oxidant stress status in chronic alcoholics by exhaled breath condensate and segmental lavage. Proceeding of the ATS 3; A428, 2006.

40. Esper AM, Martin GS, Moss M. Severe sepsis in the U.S.: The role of diabetes mellitus in organ

dysfunction and respiratory failure. Proceeding of the ATS 3; A500, 2006. 41. Danai PA, Moss M, Martin GS. The accuracy of ICD-9 codes for sepsis and severe sepsis.

Proceeding of the ATS 3; A649, 2006. 42. Mealer ML, Shelton AL, Martin GS, Burnham EL, Odom SL, Moss M. The prevalence of post

traumatic stress disorder is increased among intensive care unit nurses. Proceeding of the ATS 3; A833, 2006.

43. Dewit M, Best AM, Gennings C, Moss M. Alcohol use disorders (AUD) increase the risk of

respiratory complications in medical patients. Am J Respir Crit Care Med 175; A215, 2007. 44. Yeh MY, Burnham EL, Moss M, Brown LAS. Cysteine in the epithelial lining fluid – a potential

prognostic indicator of ARDS outcome. Am J Respir Crit Care Med 175; A757, 2007. 45. Burnham EL, Taylor WR, Sutcliffe D, Moss M. Peripheral blood mononuclear cells in ALI: a

function of endothelial repair. Am J Respir Crit Care Med 175; A899, 2007.

46. Berkowitz DM, Danai P, Eaton S, Moss M, Martin GS. Ideal body weight more accurately

characterizes extravascular lung water in acute lung injury. Am J Respir Crit Care Med 175; A947, 2007.

47. Gao L, Grant A, Rafaels N, Servansky J, Maloney J, Moss M, Shanholtz C, Brower R, Garcia

JGN, Beaty TH, Barnes KC. Variants in the myosin phosphatase target subunit-1 (MYPT1) gene are associated with acute lung injury. Am J Respir Crit Care Med 175; A949, 2007.

48. Esper AM, Brown LA, Yeh M, Moss M, Martin GS. Diabetes modulates pulmonary

inflammation in ALI. Am J Respir Crit Care Med 175; A950, 2007. 49. Mealer ML, Goode CJ, Moss M. The prevalence, overlap, and triggers of burnout syndrome and

symptoms of post-traumatic stress disorder in ICU nurses. Am J Respir Crit Care Med 177; A126, 2008.

50. Hodgin KE, Nordon-Craft A, Mealer M, Moss M. Use of physical therapy in the intensive care

units: results of two national surveys. Am J Respir Crit Care Med 177; A126, 2008. 51. De Wit M, Gennings C, Zilberberg M, Burnham EL, Moss M, Balster R. Impact of drug use

disorders on risk of mechanical ventilation in medical patients. Am J Respir Crit Care Med 177; A127, 2008.

52. Burnham EL, Edwards M, Sutcliffe D, Taylor WR, Moss M. Variability in circulating

endothelial progenitor cells between patients with acute lung injury and severe sepsis: Impact of a pulmonary etiology. Am J Respir Crit Care Med 177; A233, 2008.

53. Boe D, Richens TR, Moss M, Vandivier RW. Chronic alcohol exposure impairs phagocytosis of

apoptotic cells. Am J Respir Crit Care Med 177; A763, 2008. 54. AB Benson, A Nordon-Craft, M Schenkman, D Wegzyn, M Moss. Inpatient Physical Therapy for

Mechanically Ventilated Patients Is Independently Associated with Improved Discharge Status. Am J Respir Crit Care Med 2009; 179: A5473.

55. DB Jamieson, M Moss. Survey of Residents Knowledge and Attitudes toward Caring for

Critically Ill Patients with Alcohol Abuse. Am J Respir Crit Care Med; 2009; 179: A3117. 56. DM Boe, TR Richens, M Moss, RW Vandivier. Acute Alcohol Intoxication Impairs the

Clearance of Apoptotic Cells. Am J Respir Crit Care Med; 2009; 179: A5665. 57. EL Burnham, D Boe, J Gaydos, M Moss. Alcohol Use Disorders Decrease Antimicrobial

Proteins in Epithelial Lining Fluid. Am J Respir Crit Care Med; 2009; 179: A3224. 58. AB Benson, G Austin, C Silliman, M Moss. Transfusion Associated Acute Respiratory Distress

Syndrome (ARDS) in Patients with Gastrointestinal Bleeding: Effect of End Stage Liver Disease and the Use of Fresh Frozen Plasma. Am. J Respir Crit Care Med; 2009; 179: A4639.

59. MA Matthay, R Brower, BT Thompson, D Schoenfeld, MD Eisner, S Carson, M Moss, I

Douglas, D Hite, N MacIntyre, KD Liu. Randomized, Placebo-Controlled Trial of an Aerosolized Beta-2 Adrenergic Agonist (Albuterol) for the Treatment of Acute Lung Injury. Am J Respir Crit Care Med; 2009; 179: A2166.

60. EL Burnham, T Phang, J Gaydos, D Boe, R Winn, M Moss. Alcohol Use Disorders Alter

Alveolar Macrophage Gene Expression. Am J Respir Crit Care Med; 2009; 179: A3569. 61. KE Hodgin, ML Mealer, JP Maloney, M Moss. Insurance Status Is Associated with Differences

in Access to Care in Patients with Pulmonary Sepsis. Am J Respir Crit Care Med; Apr 2009; 179: A3747.

62. TM Bull, K McFann, M Moss. Pulmonary Hypertension Is Independently Associated with Poor

Outcome in Patients with Acute Lung Injury. Am J Respir Crit Care Med; 2009; 179: A5098. 63. Clark BJ, Marney A, Brown NJ, Moss M, Bull T. Increased Serum BNP Concentrations Are

Associated With Pulmonary Vascular Dysfunction in Patients With Acute Lung Injury. Am J Respir Crit Care Med, 2010; 181: A2582.

64. Boe DM, Richens TR, Horstmann SA, Janssen WJ, Henson PM Moss M, RW Vandivier. Acute

And Chronic Alcohol Exposure Impair The Clearance Of Apoptotic Cells And Enhance Pulmonary Inflammation. Am J Respir Crit Care Med, 2010; 181: A1267.

65. Burnham EL, Gaydos J, Brown MB, Standiford TJ, Moss M. Effect of Intravenous GMCSF In

ALI On Mobilization Of PBMCs Forming CFUs with Endothelial Features. Am J Respir Crit Care Med, 2010; 181: A6036.

66. Clark BJ, Boe DM, House R, Douglas IS, Moss M. Spectrum of Alcohol Use in The Medical

Intensive Care Unit: Opportunities For Intervention? Am J Respir Crit Care Med, 2010; 181: A4560.

67. Smart A, Clark BJ, Boe DM, Douglas IS, House R, Burnham EL, Moss M. Enabling Behaviors

In Significant Others of MICU Patients With Alcohol Use Disorders. Am J Respir Crit Care Med, 2010; 181: A4562.

68. Mealer M, Rothbaum B, Moss M. Highly Resilient ICU Nurses Are Less Likely To Develop

Psychological Symptoms And Disorders: Results Of A National Survey. Am J Respir Crit Care Med, 2010; 181: A2414.

69. Benson AB, Burton JR, Kam I, Rosen HR, Moss M. Identification Of specific Perioperative

Blood Products Associated with Transfusion-associated Acute Lung Injury and Nosocomial Pneumonia Risk in Patients Undergoing Orthotopic Liver Transplantation. Am J Respir Crit Care Med, 2010; 181: A1699.

70. Gao L, Murray T, Campbell M, Rafaels N, Maloney JP, Moss M, Martin GS, Shanholtz C, Herr

D, Sevransky J, Garcia JG, Moffatt MF, Cookson WO, Beaty TH, Brower R, Barnes K. ORMDL3 and GSDML Gene Variants Associated With Risk And Severity Of Acute Lung Injury. Am J Respir Crit Care Med, 2011; 183: A1159.

71. Clark BJ, Standiford TS, Paine R, Macht M, Benson AB, Burnham EL, Moss M. Survivors of

Acute Lung Injury with an Alcohol Use Disorder Modify Their Drinking Behaviors. Am J Respir Crit Care Med, 2011; 183: A1165.

72. Clark BJ, Moss M, Burnham EL. Effect of Alcohol Use Disorders on the outcome of Acute Lung

Injury. Am J Respir Crit Care Med, 2011; 183: A1642.

73. Macht M, Quan D, Clark BJ, Benson AB, Burnham EL, Moss M. Development Of An Efficient

Screening Test For Critical Illness Polyneuromyopathy (CIPNM). Am J Respir Crit Care Med, 2011; 183: A2649.

74. Newman J, Reese T, Moss M. Discrepancy Between Medical Intensive Care Unit (MICU)

Patients And Their Proxies Regarding Consent For Research. Am J Respir Crit Care Med, 2011; 183: A3743.

75. Finigan J, Mishra R, Nethery D, Ware L, Matthay M, Moss M, Standiford TS, Kern JA. The

HER2 Ligand Neuregulin Is Detectable And Elevated In Edema Fluid, Broncho-Alveolar Lavage And Plasma From Patients With Acute Lung Injury Compared With Controls. Am J Respir Crit Care Med, 2011; 183: A3995.

76. Eckle T, Koeppen M, Kewley E, Brodsky KS, Mariani TJ, Brodsky KS, Moss M, Eltzschig H.

Role Of Mucosal Hypoxia-Inducible Factor (HIF)1a During Acute Lung Injury. Am J Respir Crit Care Med, 2011; 183: A4012.

77. Macht M, Wimbish T, Clark BJ, Benson AB, Burnham EL, Moss M. Dysphagia Is Common,

Persistent, And Associated With Poor Outcomes In Survivors Of Critical Illness. Am J Respir Crit Care Med, 2011; 183: A4111.

78. Mealer M, Jones J, Moss M. Psychological Characteristics Of Highly Resilient ICU Nurses:

Results Of A Qualitative Study. Am J Respir Crit Care Med, 2011; 183: A4114. 79. Malcolm KC, Kret JE, Young RL, Poch KP, Douglas IS, Coldren CD, Burnham EL, Moss M,

Nick JA. Interferon-Stimulated Gene Expression Is Associated With Gram-Positive-Specific Neutrophil Dysfunction In The Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med, 2011; 183: A5237.

80. Sweatt A, Moss M, Tripputi M, Benson AB. A Dosing Formula for INR-Targeted Plasma

Transfusion in Bleeding Patients with Chronic Liver Disease. Am J Respir Crit Care Med, 2011; 183: A5828.

81. Rice TW, Wheeler AP, Thompson BT, Steingrub JS, Hite RD, Moss M, Morris A, Dong N,

Rock P. Randomized Trial Of Initial Trophic Vs. Full Enteral Feeding In Patients With Acute Lung Injury (EDEN). Am J Respir Crit Care Med 2012; 185: A6856.

82. King CJ, Macht M, Wimbish T, Clark BJ, Benson AB, Burnham EL, Moss M. Post-Extubation

Dysphagia Is Common And Associated With Longer Duration Of Hospitalization In Survivors Of Critical Illness With Pre-Existing Neurologic Impairment. Am J Respir Crit Care Med. 2012; 185: A2295.

83. Coley C, Dechert R, Harding S, Paine R, Moss M, Martin GS, Burnham EL, Flaherty KR,

Standiford T, Hyzy RC. Granulocyte Macrophage Colony Stimulating Factor Is Associated With Decreased Quality Of Life At 180 Days Post-Event When Administered To Patients With Acute Lung Injury. Am J Respir Crit Care Med. 2012; 185: A2289.

84. Coley C, Dechert R, Harding S, Paine R, Moss M, Martin GS, Flaherty KR, Standiford T, Hyzy

RC. Patients Surviving Acute Lung Injury Due To A Direct Lung Injury (ie. Pneumonia And

Aspiration) Are More Likely To Develop A Restrictive Ventilatory Defect Up To 180 Days Post-Event. Am J Respir Crit Care Med. 2012; 185: A2281.

85. Smart A, Hyzy RC, Kelly A, Quint L, Paine R, Moss M, Standiford T, Burnham EL. Reticulation

Scores On High Resolution Computed Tomography Of The Chest Predict Persistent Respiratory Symptoms In Acute Lung Injury Survivors. Am J Respir Crit Care Med. 2012; 185: A1672.

86. Tomlinson AR, Moss M, Douglas IS, House R, Smart A, Macht M, Clark BJ. Physicians

Frequently Fail To Identify Medical Intensive Care Unit Patients With Unhealthy Alcohol Use. Am J Respir Crit Care Med. 2012; 185: A1643.

87. Macht M, Wimbish T, Clark BJ, Benson AB, Burnham EL, Moss M. Diagnosis and Treatment

Of Post-Extubation Dysphagia: Results From A National Survey. Am J Respir Crit Care Med. 2012; 185: A1640.

88. Benson AB, Ridgeway K, Macht M, Clark BJ, Smart A, Schenkman M, Nordon-Craft A, Moss

M. Patient And Proxy Perceptions Of Intensive vs. Standard Physical Therapy In Critically Ill Patients. Am J Respir Crit Care Med. 2012; 185: A3078.

89. Clark BJ, Douglas IS, Burnham EL, Keniston A, Overdier K, Benson AB, Moss M. Hospital

Readmission is Common and Associated With Modifiable Risk Factors in Medical ICU Survivors with Alcohol Dependence. Am J Respir Crit Care Med. 2012; 185: A1091.

90. Clark BJ, Moss M, Overdier K, Keniston A, Burnham EL, Doody M, Douglas IS.

Dexmedetomidine as an Adjunctive Therapy for Critically Ill Patients with Severe Alcohol Withdrawal Syndrome. Am J Respir Crit Care Med. 2012; 185: A3186.

91. Malone D, Nordon-Craft A, Moss M, Edbrooke L, Schenkman M, Berney S, Denehy L. Physical

function in intensive care test: validation in a United States critical illness population. Am J Respir Crit Care Med 2013; 187:A3626.

92. Denehy L, Edbrooke L, Nordon-Craft A, Berney S, Malone D, Schenkman M, Moss M. An

Investigation Of Physical Performance Based Tests And Patient Self Report Physical Function In Survivors Of Intensive Care (ICU). Am J Respir Crit Care Med 2013; 187: A3624

93. Burnham EL, Curran-Everett D, Quint L, Kelly A, Paine R, Lynch DA, Moss M, Standiford T,

Hyzy RC. Chest High Resolution Computed Tomography (HRCT) Involvement By Reticulation Is Associated With Days On Mechanical Ventilation In ARDS. Am J Respir Crit Care Med 2013; 187: A2231.

94. Burnham EL, Wyatt T, Standiford TJ, Paine R, Moss M, Kovacs EJ, Davis CH. The Relationship

of Alcohol Use Disorders to Pulmonary Surfactant Protein D in the Presence And Absence Of The Acute Respiratory Distress Syndrome (ARDS). Am J Respir Crit Care Med 2013; 187: A4154.

95. Stratton KA, Burton JR, Bambha KM, Biggins SW, Wedd J, Macht M, Silliman CC, Rosen H,

Moss M, Benson AB. Predictive Value Of Preoperative Thromboelastogram On Perioperative Red Blood Cell Transfusion In Liver Transplantation. Am J Respir Crit Care Med 2013; 187: A1556.

96. Mealer M, Thompson BT, Oldmixon C, Wheeler A, Kahn M, Moss M. Remote Source Document Verification In The NIH Sponsored ARDS Network: A Feasibility Study. Am J Respir Crit Care Med 2013; 187: A4476.

97. Smart A, Thompson BT, Clark BJ, Macht M, Benson AB, Burnham EL, Moss M. Surrogate

Informed Consent For Genetic Substudies In ARDS Network Trials. Am J Respir Crit Care Med 2013; 187: A4448.

98. Smart A, Mealer M, Clark BJ, Macht M, Benson AB, Moss M. Monitoring Practices For NHLBI

(National Heart, Lung, And Blood Institute) Sponsored Multicenter Interventional Clinical Trials. Am J Respir Crit Care Med 2013; 187: A4457.

99. Clark BJ, Macht M, Smart A, Burnham EL, Keniston A, Benson AB, Moss M. Primary Alcohol

Related Diagnoses And Post-Discharge Follow-Up In Medical ICU Survivors With An Alcohol Use Disorder. Am J Respir Crit Care Med 2013; 187: A5310.

100. Clark BJ, Jones J, Douglas IS, Burnham EL, Moss M. Barriers And Facilitators To Change In

Medical Intensive Care Unit Survivors With Alcohol Misuse. Am J Respir Crit Care Med 2013; 187: A5286.

101. Mealer M, Conrad D, Evans, J, Jooste K, Rothbaum B, Moss M. A 12-Week Multimodal

Resilience Training Program For Intensive Care Unit Nurses: Results Of A Pilot Study. Am J Respir Crit Care Med 2014; 189: A5247.

102. Lynch Y, Evans J, Jooste K, Moss M, Mealer M. Written Exposure Therapy Reveals Common

Themes for Work-Related Traumatic Experiences In ICU Nurses. Am J Respir Crit Care Med 2014; 189: A5240.

103. Clark BJ, Ho PJM, Au DH, Bradley KA, Burnham EL, Moss M. Brief Versus Full Alcohol Use

Disorders Identification Test For The Identification Of Alcohol Misuse In Critical Illness. Am J Respir Crit Care Med 2014; 189: A5144.

104. Sottile PD, Neuman RT, Luby DM, Malone D, Nordon-Craft A, Schenkman M, Moss M.

Physical Therapy Practices In Critically Ill Hemorrhagic And Traumatic Neurology Patients. Am J Respir Crit Care Med 2014; 189: A5256.

105. Sottile PD, Lynch Y, Mealer M, Moss M. Resiliency is Associated with Less Symptoms of

Depression, Anxiety, and Improved Satisfaction in Family Members of Intensive Care Unit Patients. Am J Respir Crit Care Med 2014; 189: A1140.

106. Merritt FW, Abbott C, Fox DL, Moss M, Dorosz J, Bull TM. Echocardiographic Assessment Of Right Ventricular Strain To Detect Pulmonary Vascular Dysfunction In Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 2014; 191: A3093.

107. Clark BJ, Jones J, Douglas IS, Burnham EL, Moss M. Barriers And Facilitators To Change In

Medical Intensive Care Unit Survivors With Alcohol Misuse. Am J Respir Crit Care Med 2014; 191: A5286.

108. Clark BJ, Rubinsky AD, Ho PM, Au DH, Moss M, Bradley KA. Alcohol Screening Scores And

Risk Of Intensive Care Unit Admission In The Veterans Affairs Health System. Am J Respir Crit Care Med 2014; 191: A2179.

109. Malone D, Ridgeway K, Nordon-Craft A, Moss P, Schenkman M, Moss M. Physical Therapists

Perceptions Of Rehabilitation Practices In The Intensive Care Unit: Results Of A National Survey. Am J Respir Crit Care Med 2014; 191: A4501.

110. Malone D, Ridgeway K, Nordon-Craft A, Moss P, Schenkman M, Moss M. Staffing Patterns,

Training Methods, And Barriers To Providing Physical Therapy In The ICU: Results Of A National Survey. Am J Respir Crit Care Med 2014; 191: A5258.

111. Gu S, Burnham EL, Moss M, Clark BJ. Association of Staphylococcus Aureus and Methicillin-

Resistant Staphylococcus Aureus Colonization with Lifestyle Factors in a Nationally Representative US Sample. Am J Respir Crit Care Med 2014; 191: A1380.

112. Fini MA, McNally A, Standiford TJ, Moss M, Burnham EL. Bronchoalveolar Lavage Uric Acid

Is Elevated in ARDS and Associated With Early Ventilator Parameters. Am J Respir Crit Care Med 2015; 191: A1600.

113. Mealer M, Verran J, Jones J, Weston M, Moss M, Meek P. In Critical Care Nurses, Working in

an Medical Intensive Care Unit Has Indirect Effects on the Development of PTSD that are Mediated Through Resilience. Am J Respir Crit Care Med 2015; 191: A5228.

114. Matlock DD, Jones J, McKeehan J, Nowels C, Moss M. Making Informed Decisions About

Research Participation on Behalf of Critically Ill Patients: Defining the Needs of the Surrogate. Am J Respir Crit Care Med 2015; 191: A3783.

115. Sottile PD, Shoeb AH, Piccoli JR, Albers D, Moss M. Development of a Computerized

Algorithm to Detect and Assess the Impact of Dyssynchrony on Low Tidal Volume Ventilation. Am J Respir Crit Care Med 2015; 191: A3894.

116. Purtle SW, Kiser TH, Allen RR, Moss M. Minority Status and Male Sex are Both Associated

with an Increased Need for Renal Replacement Therapy in Sepsis-Induced Acute Kidney Injury. Am J Respir Crit Care Med 2015; 191: A5399.

117. Jolley SE, Moss M, Needham DM, Caldwell ES, Morris PE, Miller RR, Ringwood N, Andres

MG, Koo K, Parry SM, Gundel S, Hough CL. Point Prevalence Study of Intensive Care Unit Mobility Across the Acute Respiratory Distress Syndrome Network. Am J Respir Crit Care Med 2015; 191: A6349.

118. Kalra SS, Moss M, Burnham EL, Douglas IS, Reed KD, Clark BJ. Determining the Optimal

Alcohol Screening Questionnaire in the Medical Intensive Care Unit. Am J Respir Crit Care Med 2015; 191: A1381.

119. Schlepp M, Moss M, Clark BJ, Purtle SW, Benson AB. The Effect of Total Body Balance on

Developement of Post-Transfusion Hypoxemia and Non-Cardiogenic Pulmonary Edema in Critically Ill Patients with End-Stage Liver Disease. Am J Respir Crit Care Med 2015; 191: A3107.

120. Wilson KC, Checkley W, Kiser TH, Moss M, Sevransky JE, Sullivan J, Tonascia J, Vandiver

RW, Walsh J, Wise RA, Krishnan JA. Am J Respir Crit Care Med 2015; 191: A2818.

121. Kiser TH, Sevransky JE, Krishnan JA, Tonascia J, Wise RA, Checkley W, Walsh JW, Sullivan J. Wilson KC, Moss M, Vandivier RW. Corticosteroid Dosing for Acute Exacerbations of Chronic Obstructive Pulmonary Disease Requiring Ventilatory Support. Am J Respir Crit Care Med 2015; 191: A2540.

122. Nick JA, Caceres SM, Kret JE, Poch KR, Strand M, Farino A, Nichols D, Saavedra M, Taylor-

Cousar JL, Coldren CD, Geraci M, Burnham EL, Suratt BT, Fessler M, Abraham E, Moss M, Malcolm KC. Association of Interferon-Stimulated Gene Expression with Worse Outcomes in the Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 2015; 191: A2376.